Rinsho Hyoka(Clinical Evaluation)

`Original`

Original

year	vol.	no.	page	article's title	author
1973	1	1	27	A Double-Blind Controlled Study on the Clinical Efficacy of Four Antidepressant Drugs－clomipramine, dimethacrine, nortriptyline, and protriptyline	Hitoshi Itoh	Yukio Kawakita	Yoshio Kudo	Yorio Satoh	et al.
1973	1	1	52	The effect of a new analgesic Seda Kyorin on cancerous pain compared with sulpyrin a controlled, double-blind cross study.	Yukimitsu Tai	Kouichi Kaneda	Toshihiko Tanaka	Kouichi Yatomi	et al.
1973	1	1	71	A controlled clinical trial of Methylcobalamin in the treatment of peripheral neuropathy－A comparison of 1500μg/day with 120μg/day oral administraation－	Kyotaro Abe	Mitsuo Iida	Tetsuo Inokuchi	Tsugio Okada	et al.
1973	1	1	77	Double Blind Study of Cinnarizine on Cerebrovascular Diseases	Yorio Satoh	Masanao Kurihara	Hitoshi Itoh	Yoshiaki Tazaki	et al.
1973	1	1	96	The Validity of Psychoneurosis Rating Scale for Symptom on the differential diagnostic use between normal and psychoneurosis	Seiichi Ichimaru	Hitoshi Itoh	Yukio Kawakita	Masanao Kurihara	et al.
1973	1	1	113	Comparison of three kinds of antiparkinsonian agents(Piroheptine=FK-1190, Trihexyphenidyl and Promethazine) in drug-induced extrapyramidal symptoms using double-blind technique	Sadanori Miura	Masashi Takesada	Nobuo Tanaka	et al.
1973	1	2,3	139	Clinical Effect of Placenta Extract "PLP injection" on Gastric Ulcer －Comparison of PLP injection with Basic Aluminium Sucrose Sulfate by Double Blind Test Method－	Yasuhiko Odori	Fumio Mizuno	et al.
1973	1	2,3	149	Further Analysis of the Double-Blind Controlled Study on the Clinical Efficacy of Four Antidepressant Drugs－Imipramine, Trimipramine, Safrazine, Amitriptyline	Yorio Satoh	Seiichi Ichimaru	et al.
1973	1	2,3	167	A Survey and study on Extra-Normal validity of The CPRG Depression Rating Scale For Patient's Use	Masazumi Shinozaki	Ikuo Hasue	Hideto Mori	Kenpei Miyakawa	Yorio Satoh
1973	1	2,3	181	Double blind controlled study of mesoridazine and thioridazine on schizophrenic inpatients	Hideto Mori	Motoo Arai	et al.
1973	1	2,3	213	Double blind cross-over comparison of clinical efficacy among two cholagogous,3-chloropyridazinyl-6-mercaptoacetic acid diethylamide and oxaphenamide,and placebo on cholestatic diseases.	Akima Miyoshi	Yorio Satoh
1973	1	2,3	219	Double Blind Study of the Effects of Lysozyme Eye Drops on Oculopathy	Masato Hayakawa	Sachio Uchida	Kazuko Kameyama	Yasuo Niwa
1973	1	2,3	233	A case report of thallium intoxication	Muneo Shimizu	Yasunori Oana	Takayuki Saruhara	Kakumi Kurohane	Yorio Satoh
1973	1	2,3	239	Two fatal cases in the course of double-blind study of two antidepressants,doxepin and imipramine	Sousuke Tobisawa	Kenji Tsuburaya	Koichiro Shirahashi
1973	1	2,3	243	The double-blind controlled study on the mucolytic effects of S-carboxymethylcysteine orally administered.	Genichi Tanaka	Shigeru Nagaoka	Mitsuaki Endo	Shinichi Tanimoto
1974	2	1	9	The effect of Butoxybenzyl Hyoscyamine Bromide as a pretreatment agent on X-ray examination using double-blind technique	Takeshi Tomioka	Kunihiko Sakaguchi	Katsunori Saigenji	Kunio Nanka
1974	2	1	23	Comparison of Efficacy of Lithium Carbonate and Chlorpromazine in Mania by Double-Blind Controlled Study	Kozo Itoh	Hitoshi Itoh	Masanao Kurihara	et al.
1974	2	1	47	A Double Blind Cross-Over Study of Clomipramine, Amitriptyline and Placebo on enuretic patients	Ryuichi Oogoshi	Yukio Fukuyama	et al.
1974	2	1	69	Clinical Trials of Timepidium Bromide（SA-504）for the Treatment of Abdominal Pain in Gastrointestinal Disease（A Double-Blind Controlled Trial）	Kiyoko Imamura	Makoto Osada	et al.
1974	2	1	105	A Double Blind Controlled Study of FX-501 on the Clinical Efficacy for Abdominal Pains	Masayoshi Namiki
1974	2	1	121	Paradoxical behavioral reaction with skin rash after receiving amitriptyline	Toshihiro Takaishi
1974	2	2	139	PhaseⅠ Study of 2-Phenyl-5-benzothiazoleacetic acid(K-308) Ⅰ.A Single-dose study	Hideo Miyashita	Naokata Shimizu	et al.
1974	2	2	157	PhaseⅠ Study of 2-Phenyl-5-benzothiazoleacetic acid(K-308) Ⅱ.A multiple-dose study	Hideo Miyashita	Naokata Shimizu	et al.
1974	2	2	169	Comparison of Clinical Efficacy of Clozapine and Haloperidol in Schizophrenia using Double-Blind Techniquie	Sadanori Miura	Iwao Tashiro	et al.
1974	2	2	207	Therapeutic Effect of Timepidium Bromide(Sesden) on Abdominal Pain due to Gastrointestinal Diseases－Evaluation by Double Blind Test－	Taneomi Okuhara	Goro Kajiyama	et al.
1974	2	2	229	A clinical evaluation of Glycopyrronium bromide on the peptic ulcers in the method of double blind controlled trial	Taneomi Okuhara	Takashi Kai	et al.
1974	2	2	247	A Comparative Double-Blind Clinical Study of Fluocinonide with Betamethasone Valerate
1974	2	2	259	A Double-Blind Comparison of the Therapeutic and Side Effects of the Syrup and Tablet forms of Antihistaminic Drug, Tavegyl in Urticaria
1974	2	2	271	A Doube-Blind Controlled Study on the Clinical Efficacy of Topical Betamethasone 17,21-Dipropionate
1974	2	3	335	A Double-Blind Controlled Study of Ca Hopantonate and Pyrithioxine in Conformity to a Rating List for the Evaluation of the Abnormal Behaviors in Children（Ⅰ）
1974	2	3	365	A Double-Blind Controlled Study of Ca Hopantenate and Pyrithioxine in Conformity to a Rating List for the Evaluation of the Abnormal Behaviors in Children（Ⅱ）
1974	2	3	375	A Double-Blind Controlled Study of Ca Hopantenate and Placebo in Conformity to a Rating List for the Evaluation of the Abnormal Behaviors in Children（Ⅲ）
1974	2	3	385	Double-blind cross-over study of the clinical efficacy of nimetazepam (S-1530) on insomnia in comparison of nitrazepam and placebo	Hitoshi Itoh	Tetsuya Hirose	et al.
1974	2	3	409	A Double-blind Comparison of PJ-929 with Carpipramine in Chronic Schizophrenia	Haruhiko Naito	Sumio Sato	et al.
1974	2	3	429	Effect of Citicoline(CDP-choline) on Cerebrovascular Diseases －A controlled clinical trial with a double-blind method－	Eiichi Ohtomo	Shinzaburo Koshijima	et al.
1974	2	3	441	A Double-Blind Controlled Trial on The Antivertigious Effect of CDP-Choline(NICHOLINE) in The Cases with Posttraumatic Dizziness	Y.Koike	M.Nagaba	et al.
1975	3	1	19	Clinical efficacy of so-called brain metabolism activating agents in treatment of cerebrovascular disorders－A double-blind controlled study on the clinical efficacy of meclofenoxate and pyrithioxine in cerebrovascular disorders－
1975	3	1	47	A double-blind controlled study of a β-glucuronidase inhibitor, aceglatone, on dysfunctional uterine bleeding	Tsutomu Ishiwara	Ryo Yonekura	et al.
1975	3	1	55	Comparison of Efficacy of M-2H,Bromvalerylurea,Nitrasepam and Placebo for Insomniac Patients by Double-Blind Controlled Study	Ryuichi Kodama	Yoshiyuki Shibata	et al.
1975	3	1	71	Double-blind cross-over study of the effect of LS-121 on cerebrovascular disease	Y.Tsunashima	Y.Kobayashi	et al.
1975	3	2	135	PhaseⅡ Study on New Anti-inflammatory Agent 2-Phenyl-5-Benzothiazoleacetic Acid(K-308)－Clinical use in the treatment of acute inflammatory disease of the respiratory tract－	Syoji Kudo
1975	3	2	149	A Multi-Clinic Double-Blind Controlled Study on The Clinical Efficacy of Dimetacrine and Amitriptyline in Depression	Takuro Noguchi	Michio Okada	et al.
1975	3	2	177	Comparison of Clinical Effect on Neurosis of Lorazepam, Diazepam and Placebo using Double Blind Technique	Nobuo Ohtsuka	Sadanori Miura	et al.
1975	3	3	297	A Multi-institutional Double Blind Controlled Study of Dilazep (AS-05) on the Effect for Ischemic Heart Diseases	Mitsuo Hisamatsu	Takashi Fujita	et al.
1975	3	3	319	The Efficacy of L-DOPA on Alopecia in the Method of Double Blind Controlled Study
1975	3	3	329	Evaluation of Bencyclane on Cerebral Vascular Diseases－Multi-center, double-blind study in comparison with cinnarizine and placebo－	Takeshi Honma	Shigeo Hasegawa	et al.
1975	3	3	357	Clinico-Pharmacological Study of Ifenprodil (FX-505)－Ⅰ.Study of urinary excretion and clinical safety in man	Hiroshi Kawai
1975	3	3	377	Clinico-Pharmacological Study of Ifenprodil (FX-505)－Ⅱ.Effects of Ifenprodil on the cerebral hemodynamics in young adults and CVD patients－	Jiro Kaneko	Junzo Shiraishi	Hisashi Inaoka
1975	3	3	387	Double Blind Study of FX-505 (Ifenprodil) on Cerebrovascular Disease－Phase Ⅱ Study－	Ryuichi Kodama	Yasushi Maki	et al.
1976	4	1	21	Clinical Evaluation of Proglumide on Peptic Ulcers by Double Blind Test Method	Kazunori Ida	Yoshihiro Kori	et al.
1976	4	1	41	A Double-Blind Comparative Study on the Clinical Efficacy of Topical Betamethasone 17-benzoate
1976	4	1	61	The Evaluation of Clinical Effects of Lucidril on the Psychiatric Symptoms of Patients with Cerebro-vascular Disorder	Toru Kawajiri	Osamu Yamada	Nobuo Yauchi	Masahiro Ota
1976	4	1	79	A Double-Blind Controlled Study on the Clinical Efficacy of New Antihypertensive Agent; Bietaserpine
1976	4	1	101	Comparison of Clinical Effects of Penfluridol, a Long-Acting Oral Neuroleptic, and Perphenazine in Schizophrenia using Double-Blind Technique	Sadanori Miura	Gohei Yagi	et al.
1976	4	1	131	A Clinical Effect of Ko 1366 on Angina Pectoris－A Comparative Double-Blind Clinical Study with Propranolol－	Kizuku Kuramoto	Akira Sakuma	et al.
1976	4	2	189	A Double Blind Controlled Study on the Clinical Efficacy of Antiinflammatory Analgesic, 31252-S on Orthopedics－The comparison of 31252-S, benzydamine hydrochloride and placebo－	Nobuyasu Ichikawa
1976	4	2	213	Clinical Efficacy of Pentoxifylline (BL 191) and Pyrithioxine Hydrochloride (PTX) in Treatment of Cerebrovascular Disorders－A double blind controlled study－	Goro Araki	Katsuya Itahara	et al.
1976	4	2	231	Effect of Cyanocobalamine Ophthalmic Solution on Experimental Asthenopia
1976	4	2	241	Effect of Cyanocobalamine Ophthalmic Solution on Experimental Asthenopia－By using Accommodometer, Osaka Univ.－
1976	4	2	247	A Multicenter Double Blind Study of Carbenoxolone Sodium for Patients with Gastric Ulcer in Japan, Evaluated by Group Comparison with Nonparametric Analysis	Makoto Ishikawa	Takeo Wada	et al.
1976	4	2	271	A Side Effect Check System Model by Pattern Analysis	Haruko Shikimori	Kazuko Sei	Toshiharu Fujita
1976	4	3	351	A Double-blind Controlled Study on the Usefulness of Carpipramine-Chlorpromazine Combination in the Pharmacotherapy of Chronic Schizophrenic Patients	Osamu Inoue	Kozo Itoh	et al.
1976	4	3	405	Clinical Evaluation of Ketoprofen in Pain Clinic Field by a Double Blind Controlled Study	Osamu Aochi	Yukio Goto	et al.
1976	4	3	419	Double Blind Study of FX-505 (Ifenprodil) on Cerebrovascular Diseases －Phase Ⅲ Study－
1976	4	3	459	Clinical Investigation on the Haemostatic Effects of Estrogen-progestogen Combination (SH-850), Reference Drug (Equivalent to 2 tablets Norluten D) and Placebo in the Treatment of Functional Uterine Bleeding by Comparative Double Blind Method	Tsutomu Ishihara	Masami Saitoh	et al.
1976	4	3	477	Comparison of Clinical Efficacy of K-315 and Pentazocine in Postoperative Wound Pain Using Double Blind Techinique	Hiroshi Akimoto	Akiharu Sasaki	et al.
1976	4	3	507	A Double-Blind Controlled Study on the Clinical Efficacy of Topical Clobetasol 17-Propionate
1977	5	1	7	Phase Ⅲ Study of Anti-inflammatory Agent, 2-Phenyl-5-benzothiazoleacetic Acid (K-308)－A double blind controlled trial on acute upper respiratory infections－	Takashi Furuie	Junzaburo Kabe	et al.
1977	5	1	23	Phase Ⅲ Study of 2-Phenyl-5-benzothiazoleacetic Acid (k-308)－A double-blind controlled trial of 2-phenyl-5-benzothiazoleacetic acid in the treatment of pain and subjective signs followed on tonsillectomy－	Kazumitsu Ishikawa	Hatsuo Ino	Osamu Kitami
1977	5	1	31	Clinical Evaluation of Protizinic Acid for Neck, Shoulder and Arm Symdrome with Double Blind Method	Toyoji Ueo	Hideo Watanabe	et al.
1977	5	1	55	Clinical Evaluation of Protizinic Acid on Diseases in Orthopedics －Double Blind Controlled Study on Neck, Shoulder and Arm Pain Compared with Mepirizole－	Masahiro Ishihara	Tsunemaru Yoshida	et al.
1977	5	1	83	Double Blind Clinical Trial of Protizinic Acid on Episiotomy Compared with Mepirizole and Placebo	Hirosuke Takekida	Motoo Washio	et al.
1977	5	1	103	A Double-Blind Study on Clinical Efficacy of Urea Ointment
1977	5	1	127	Therapeutic Effect of Isoxsuprine Hydrochloride (Duvadilan) on the Glaucomatous Visual Field Changes－A Double Blind Controlled Study－	Harumi Nose	Hiroshi Koike	et al.
1977	5	2	189	A Multi-institutional Double Blind Control Study to Compare the Effectiveness of TM-906 and Metoclopramide in Controlling Functional Gastrointestinal Symptoms	Sho Isogai	Toshie Onuki	et al.
1977	5	2	205	A Double-blind Cross Over Study of Panabolide on the Male Infertility	Sadao Kamidono	Keizo Shida	et al.
1977	5	2	213	Double-blind Study on the Clinical Effect of Beclomethasone Dipropionate Inhaler and Its Placebo in the Treatment of Steroid-independent Bronchial Asthma
1977	5	2	231	Double-blind trial to Compare Bitolerol and Trimetoquinol in Bronchial Asthma	Yoshihiko Horiuchi	Shoichi Nakagawa	et al.
1977	5	2	255	Evaluation of Mepitiostane for Advanced Breast Cancer－A double-blind controlled study－
1977	5	2	305	Clinical Evaluation of Indenolol in Angina Pectoris by Double Blind Crossover Study with Alprenolol	Satoshi Ohta	Michio Ogasawara	et al.
1977	5	2	341	Double-Blind Comparison of Clinical Effects of ID-540,(Fludiazepam) Diazepam and Placebo on Psychoneuroric Patients and a Tentative Draft of Dependency Questionnaire	Masaya Jimbo	Tetsuya Hirose	et al.
1977	5	2	369	Comparison of Clinical Efects of Clotiazepam, Diazepam and Placebo on Neurosis Using Double Blind Technique	Kozo Itoh	Koichi Itoh	et al.
1977	5	2	435	A Case of Lithium Intoxication with Neurological Sequelae	Masanao Kurihara	Masanobu Uchigata	et al.
1977	5	3	467	Clinico-pharmacological Study on Obsessional Neurosis and Phobia with Bromazepam, Haloperidol, Imipramine and Placebo	Toshiyuki Naito	Mitsuyuki Ikeda	Yukio Suzuki	Yukio Takahashi	Hiroshi Utena
1977	5	3	493	A Double Blind Controlled Study on the Clinical Effects of Pranoprofen in Low Back Pain and Cervical Pain －Comparison with flufenamate･Aluminium－	Yutaka Miyanaga
1977	5	3	535	Clinical Evaluation on Anti-Swelling Drug-A-4700(Reparil Tablet) in Orthopedic Field－A Comprehensive Double Blind Controlled Trial Compared with Serratiopeptidase and Placebo in 20 Orthopedic Clinics－	Yoshio Oi	Makoto Furuya	et al.
1977	5	3	577	A Double-Blind Controlled Study of the Clinical Efficacy of Topical Bendazac
1977	5	3	597	A Double-Bliond Controlled Study on the Clinical Utility of Topical Fluocortolone
1977	5	3	633	Evaluation of Antihypertensive Effect and Clinical Usefulness of Mebutamate
1977	5	3	659	Clinical Evaluation on the Effect of Cyclandelate in the treatment of Cerebrovascular Diseases－Double-blind comparative placebo-controlled clinical study with cinnarizine as a basic treatment－	Masao Kase	Takashi Kutsuzawa	et al.
1978	6	1	15	A Double Blind Controlled Study on the Hemostatic Effect of Synthetic Estrogen and Gestagen Combination Drug, SH 850 on Functional Uterine Bleeding	Seiji Matsuda	Kiyoshi Saitoh	et al.
1978	6	1	29	Phase Ⅰ Study of ID-4708, A Butyrophenone type Antipsychotic －A single dose study－	Seiichi Ichimaru	Yoshio Kudo	Osamu Shimada
1978	6	1	45	A Clinical Effect of Dilazep (AS-05) on Ischemic Heart Diseases －A Comparative Double Blind Clinical Study with Prenylamine－	Kenichi Harumi	Kizuku Kuramoto	et al.
1978	6	1	69	A Multi-Clinical Double-Blind Controlled Study on the Clinical Efficacy of Proglumide in Gastric Ulcers	Yoshihiro Kohli	Soro Takeda	et al.
1978	6	1	85	The Hypotensive Effects of Propranolol Compared with Those of Practolol over a Prolonged Period	T. Fujise	A. Sakuma	et al.
1978	6	1	99	The Comparative Efficacy of Maprotiline and Amitriptyline in Depression by Multi-Centre Double Blind Trial and the Characteristics of Maprotiline	Atsuyoshi Mori	Takuro Noguchi	et al.
1978	6	2	145	Effect of Oral Administration of Tioponin on Senile Cataracts －A Double Blind Clinical Study－	Kitetsu Imaizumi	Yutaka Tazawa	et al.
1978	6	2	167	Therapeutic Effects of Lysozyme and Tiopronin on Chronic Active Hepatitis－A Double Blind Clinical Trial－	Hiroshi Suzuki	Tatsuro Takino	et al.
1978	6	2	201	Clinical Effects of Lorazepam on Insomnia in the Field of Internal Medicine－Evaluated by Double Blind Study Using Nitrazepam and Placebo as Control Drugs－	Tatsuro Kokubu	Einosuke Ueda	et al.
1978	6	2	223	Comparison of Clinical Efficacy of Methixene, Trihexyphenidyl and Promethazine in Drug-Induced Parkinsonism Using Double Blind Cross-over Technique	Gohei Yagi	Teruyoshi Kobayashi	et al.
1978	6	2	273	Clinical Effects of Pyrihioxine in Treatment of Cerebrovascular Disorders －A Double Blind Controlled Study with Placebo－	Teruo Omae	Shoshiro Kuromaru	et al.
1978	6	2	291	Evaluation of the Clinical Efficay of So-called Brain Metabolism Activating Agents on Consciousness of Acute Cerebrovascular Diseases－Evaluation of Meclofenoxate Hydrochloride Injection by a Double-blind Method－
1978	6	2	317	Clinical Effects of RONICOL Timespan for Peripheral Circulatory Disorders
1978	6	2	333	Evaluation by the Double Blind Method of Long Term Effect of Antihyperlipidemic Agent on Hyperlipidemia	Hajime Orimo	Chikayuki Naito	et al.
1978	6	3	379	Double-Blind Controlled Study on the Efficacy of Topical Diflucortolone Valerate
1978	6	3	411	Results of a Double-Blind Controlled Trial to Compare Lipoclin and Clofibrate	Yuichi Yamamura	Teruo Omae	et al.
1978	6	3	441	The Therapeutic Effect of S-8527 (Lipoclin) on Hyperlipidemia －Double Blind analysis of S-8527 with Clofibrate－	Youichi Umetada	Tsutomu Hara	et al.
1978	6	3	463	Clinical Evaluation of S-8527 (Lipoclin) in Hyperlipidemia by Double Blind Study with Nicomol	Noboru Yoshimine	Michihiro Kitagawa	et al.
1978	6	3	483	Double-blind Comparative Trial of S-8527 (Lipoclin) and Clofibrate on Hyperlipidemia	Iwao Fukui	Yochinori Akazawa	et al.
1978	6	3	511	Evaluation of Inhalated Lysozyme Ohloride, in Nebulizer Treatment upon Paranasal Sinusitis	Hitoshi Saito	Yahachiro Toyoda	et al.
1978	6	3	533	A Double Blind Study of Protizine Acid －Clinical Investigation on Trauma and Postoperative Symptoms－	Masaaki Funaki	Iwao Shiga	et al.
1978	6	3	563	Study on the Effects of Clofedanol, A New-Antitussive, by Double Blind Method －In Comparison with Dextromethorphan－
1979	7	1	11	Clinical Evaluation of MK-950 in Angina Pectoris Using Double-Blind Cross-over Technique with Propranolol	Mototaka Murakami	Toshio Ozawa	et al.
1979	7	1	27	The Comparative Evaluation of Talampicillin Hydrochloride with Amoxycillin on Bacterial Pneumonia Patients by Double Blind study	Yutaka Ohsaki	Akira Saito	et al.
1979	7	1	49	Double-blind, Cross-over Study of the Effects of Ritalin, Sp-732 and Placebo on Narcolepsy
1979	7	1	83	A Double-Blind Study on Utility of Econazole Cream in Dermatomycosis
1979	7	1	109	Clinical Evaluation of Metoprolol, A Cardioselective Beta-Blocker on Angina Pectoris －Double-blind Comparison with Propranolol－	Hideo Miyashita	Yoshiro Nakamura	et al.
1979	7	1	137	Clinical Evaluation of the α-HCC (1 α-Hydroxycholecalciferol) on Hypocalcemia of Hemodialysis Patients －Comparison with Vitamin D２ by a double blind controlled clinical study－	Yosuke Ogura	Shozo Koshikawa	et al.
1979	7	1	157	The National Epidemiological Study of the Newly Admitted Patients of Drug Abuse in Mental Hospitals in japan during 1976	Takemitsu Henmi	Eiko Kurisu	Haruko Shikimori	Toshiharu Fujita
1979	7	2	205	A Double-blind Clinical Study on the Expectorant Effect of Seaprose-S	Motoichi Tanaka	Eiro Tsubura	et al.
1979	7	2	233	Phase Ⅰ Study of Y-8910, A new Butyrophenone Derivative	Seiichi Ichimaru	Yukio Kawakita	Osamu Shimada
1979	7	2	265	Clinical Evaluation of Indomethacin Ointment in the Minor Trauma (contusion, bruise and sprain) －A Double-Blind Comparative Trial of Indomethacin Ointment－	Hideya Hanaoka	Mitsuyoshi Uzawa	et al.
1979	7	2	285	A Double Blind Controlled Study of Indomethacin Ointment －Clinical Investigation in the Orthopaedic Field－	Kanji Hichikawa	Masaki Tsujimoto	et al.
1979	7	2	311	Therapeutic Effect and Safety of FR 1949 on Biliary and Pancreatic Disease －Evaluation by Double-Blind Test－	Akima Miyoshi	Yoshimi Tamazawa	et al.
1979	7	2	323	Clinical Evaluation of Tolperisone (Muscalm) in Bronchial Asthma －Comparative Study with Control Drug Trimetoquinol by Double Blind Cross-Over Method－	Hitoshi Nagano	Mitsuru Iwakura	et al.
1979	7	2	349	Clinical Evaluation of Cinepazide in the Treatment of Cerebrovasucular Disorders －Multi-center double-blind study in comparison with placebo－
1979	7	2	379	A Double-Blind Study Comparing Behyd W (a combination drug of Behyd and Mebutamate) with Behyd as the Reference Drug
1979	7	3	437	Double Blind Study on Clinical Effects on Ganmalon in The Cerebro-Vascular Disorders	Sunao Sato	Tsuneo Nishimura	et al.
1979	7	3	459	A Double-Blind Controlled Clinical Study of FM-100 in Gastric Ulcer	Akima Miyoshi	Takashi Miwa	et al.
1979	7	3	509	Comparison of Anti-Manic Efficacy of Carbamazepine and Chlorpromazine by Double-Blind Controlled Study	Kazutoyo Inanaga	Saburo Otsuki	et al.
1979	7	3	533	Clinical Evaluation of ID-4708, a Newly Synthesized Butyrophenone Derivative, on Schizophrenia－Early Phase Ⅱ Open Trial－	Kaizawa Shigeo	Sadanori Miura	et al.
1979	7	3	565	Clinical Pharmacological Study of Nomifensine a New Antidepressant －Viewed from drug dependence－	Masanao Kurihara	Takemitsu Henmi	et al.
1979	7	3	587	A Clinical Trial on Dependence Liability of a New Oral Antidiarrheal Agent, Loperamide Hydrochloride	Eiichi Sugimoto	Toru Abei	et al.
1979	7	3	603	Double-Blind Controlled Study on the Efficacy of Topical Halcinonide	et al.	(Clinical Research Group for Halcinonide)
1979	7	3	633	Follow-up Study on "Effect of Oral Administration of Tiopronin on Senile Cataracts"	Kitetsu Imaizumi	Yutaka Tazawa et al.	et al.
1980	8	1	19	Clinical Evaluation of GABA in the Treatment of Cerebrovascular Disorders－Multi-center double-blind study in comparison with pyrithioxine and placebo－	et al.	(Cooperation Study Group on Clinical Evaluation of GABA)
1980	8	1	79	A Study of the Clinical Efficacy of Triazolam on Insomnia－Double-blind Cross-over Study among the Smaller and Larger Doses of Triazolam, and Flurazepam－	Masaya Jinbo	Tetsuya Hirose	et al.
1980	8	1	111	Clinical Evaluation of GB94 (mianserin hydrochloride) on Antidepressant Effects Using Double-Blind Comparative Technique with Imipramine	et al.	(Hokkaido Clinical Psychopharmacological Research Group)
1980	8	1	149	Clinical Evaluation of U-600 on Gastric Ulcer	Tadayoshi Takemoto	Itaru Ohi	et al.
1980	8	1	169	A Double-Blind Study on the Optimum Dose of Atenolol in Essential Hypertension
1980	8	1	197	A Randomized, Double Blind Controlled Trial of the Efficacy of Stronger Neo-Minophagen C for the Prevention of Post-transfusion Hepatitis	Kaneo Kikuchi	Akira Tateda	et al.
1980	8	1	215	Improving Effect of Prostagladin F2α（PGF2α) on Post-Laparotomy Intestinal Paralysis－Double-blind Study with Pantethine－	katsuhiko Sugahara	Shoetsu Tamakuma	et al.
1980	8	1	235	A Double-Blind Controlled Trial of Azatadine Maleate Syrup (Idulamine Syrup) in Children with Urticaria or Atopic Dermatitis	Toru Akasaka	Minoru Baba	et al.
1980	8	2	321	Clinical Evaluation of Tamoxifen in Advanced Breast Cancer (Primary & Recurrent)－Double Blind Study－	et al.	(Double Blind Study Group of Tamoxifen)
1980	8	2	353	Clinical Evaluation of HC20-511 (Ketotifen), a New Orally Anti-Anaphylactic Compound, in Bronchial Asthma Ⅰ.Multi-center double-blind study in comparison with placebo
1980	8	2	397	PhaseⅠ Study of R 343 01, A New Benzamide Derivative	Yoshio Kudo	Yukio Kawakita	Seiichi Tanaka	Osamu Shimada
1980	8	2	437	Clinical Evaluation with Indapamide on Patients with Essential Hypertension in 22 Medical Institutions －Study on Dose Response by Double-Blind Method－	Masao Ikeda	Nagao Kajiwara	et al.
1980	8	2	457	A Double-blind Clinical Study of Ketoprofen on Acute Upper Respiratory Infection－Comparison with Aspirin－	Shigeru Nagaoka	Asao Hamada	et al.
1980	8	2	481	Clinical Effects of SH 582 (Gestonorone caproate) on Prostatic Hypertrophy －in comparison with Paraprost by double-blind technique－	Kenichiro Okada	Masuji Kuse	et al.
1980	8	2	517	Attitude of Patients Toward Informed Consent in Clinical Trial of New Drug	Akira Kishimoto	Yuzuru Sunami	Kazuyoshi Nakazawa	Masashi Imaoka	Hidefumi Hazama
1980	8	3	553	Clinical Evaluation of YC-93(Nicardipine hydrochloride) and Pentoxifylline in the Treatment of Cerebrovascular Disorders －A double-blind controlled study－	Shunsaku Hirai
1980	8	3	577	Clinical Utility of Eunal in Treatment of Cerebrovascular Disorders －Multi-center double-blind study in Comparison with Dihydroergotoxine mesylate－	et al.	(Research Group for Eunal Phase Ⅲ Clinical Study)
1980	8	3	629	A Multi-centered Double Blind Trial of Pimozide (Orap), Haloperidol and Placebo for Abnormal Behavior in Children Using Crossover Design
1980	8	3	675	Comparative Clinical Study on Effectiveness and Safety of Cinnarizine and Betahistine on Vertigo by Double-blind Trial Test	Hideo Saito	Manabu Hinoki	et al.
1980	8	3	719	Clinical Evaluation of Anginal in Ischemic Heart Diseases with Reference to Adequate Dose	Kyozou Ishikawa	Satoshi Ohta	et al.
1980	8	3	747	A Multicenter Double-blind Study on the Efficacy of Carbenoxolone Sodium for Japanese Patients with Duodenal Ulcer in Japan	Tetsuro Taneda	Makoto Ishikawa	et al.
1980	8	3	757	Therapeutic Effects of Fentiazac on Common Cold －A Double-blind Clinical Study－	Fumio Nagahama	Kiyoshi Konno	et al.
1980	8	3	789	Clinical Evaluation of Timolol in the Treatment of Patients with Ocular Hypertension and Primary Open Angle Glaucoma Who have been Controlled on Pilocaprine －Double blind study－	Ikuo Azuma	Yoshiaki Kitazawa	et al.
1980	8	3	821	A Clinical Study with Metoprolol on Efficacy and Usefulness in Essential Hypertension －Double-Blind Comparative Study on Metoprolol with Reserpine－	et al.	(Study Group of CF-15)
1981	9	1	13	PhaseⅠ Study of TCUK (Urokinase Derived from Tissue Culture Process)	Hideo Miyashita	Masami Yamanaka	et al.
1981	9	1	25	Clinical Evaluation of N-(2-ethylhexyl)-3-hydroxybutyramide hydrogen succinate (M-2H) by Double-Blind Cross-Over Study on Insomnia－Double-Blind Cross-Over Study in Comparison with Bromvalerylurea－	Goro Araki	Takeshi Tomita	et al.
1981	9	1	71	Clinicopharmacological Studies of Hypnotics －A controlled, double-blind study of estazolam, a new hypnotic, nitrazepam and placebo－	Hiroyuki Aoki	et al.
1981	9	1	99	A Double-blind Clinical Trial of the Effect of Sfericase, a Proteolytic Enzyme, on Sputum and Determination of Sfericase in Serum	Eiichi Yamanaka	Keiichi Nakagawa	et al.
1981	9	1	117	A Double-Blind Controlled Study on the Clinical Effects of CH-800 (Fentiazac) for Low Back Pain －Comparison with Diclofenac Na－	Yoshio Oi	Ryuzo Mikami	et al.
1981	9	1	135	Clinical Evaluation of Fentiazac in the Treatment of Osteoarthritis of the Knee －A double-blind clinical study in comparison with Diclofenac Na－	Torakichi Aoki	Mitsuo Igarashi	et al.
1981	9	1	159	Clinical Evaluation of Bupranolol Hydrochloride Drop in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension－Multi Center Double-Blind Study in Comparison with Pilocarpine Drop－	Ikuo Azuma	Masahiro Takase	et al.
1981	9	1	225	TEN Type Drug Eruption by α-methyldopa	Toshiyuki Funabashi
1981	9	2	261	Comparison of Clinical Effect on Neurosis of Oxazolam, Diazepam and Placebo Using Double Blind Cross Over Technique	Ryo Takahashi	Yoshio Kudo	et al.
1981	9	2	319	Comparison of Clinical Effect on Neurosis of Mexazolam, Diazepam and Placebo Using Double Blind Technique	Shigeo Kaizawa	Sadanori Miura	et al.
1981	9	2	355	Effect of Melinamide on Serum Lipids －Clinical Evaluation by Double Blind Study－	et al.	(Double Blind Study Group Melinamide)
1981	9	2	391	Eeffects of E-0646 on Cases of Spasticty －A Double Blind Comparison Using Tolperisone Hydrochloride－	Itsuro Sobue	Yoshiaki Tazaki	Takao Nakanishi	Eiichi Ohtomo	Katsuya Itahara
1981	9	2	421	Clinical Evaluation of Urine Alkalinizing Agent CG-120 (Uralyt-U) －Mluti-Center Well-Controlled Open Study in Comparison with Sodium Bicarbonate－	Katsuki Kawabe	Ieo Akaoka	Naokata Shimizu	Yorio Satoh	et al.
1981	9	2	435	Clinical Evaluation of the Effect of Fenoprofen Calcium against Osteoarthritis of the Knee －Double-blind Comparative Trial－	Hiroshi Aritomi	Wataru Kawaji	et al.
1981	9	2	461	A Double-blind Controlled Study of Azatadine Maleate Tablet (Idulamine) on Urticaria and Pruritus Cutaneus	Takashi Harada	Wataru Naka	et al.
1981	9	2	501	Double-Blind Controlled Study on the Clinical Efficacy of Topical Prednisolone 17-Valerate 21-Acetate	et al.	(Clinical Research Group for Prednisolone 17-Valerate 21-Acetate)
1981	9	3	577	Phase Ⅰ Study of Sultopride (New Benzamide Derivative)	Shun Yamazumi	Kurefu Okamoto	et al.
1981	9	3	629	Clinical Evaluation of Comelian (Dilazep) in the Treatment of Cerebrovascular Disorders －Multi-Center double-blind study in comparison with Pentoxifylline－	et al.	(Cooperation Study Group on Clinical Evaluation of Comelian)
1981	9	3	673	Clinical Evaluation of HOPA (HOPATE) in the Treatment of Cerebrovascular Disorders －Multi-center double-blind study in comparison with Ifenprodil tartrate and placebo－	et al.	(Cooperation Study Group on Clinical Evaluation of HOPA)
1981	9	3	711	A Clinical Evaluation of a New Antianxietic Drug, Alprazolam, on Psychosomatic Diseases and Neuroses	Tetsuya Nakagawa	Ken Fukamachi	et al.
1981	9	3	733	Clinical Evaluation of Flunitrazepam on Insomnia in Neuropsychiatric Field －A Comparative Double-Blind Cross-Over Study with Nitrazepam－	Gohei Yagi	Masato Tateyama	et al.
1981	9	3	769	Anti-anginal Effects of Ko 1366, a Beta-blocker －A Multiclinical Double-blind Comparison with Propranolol－	Kizuku Kuramoto	Akira Sakuma	et al.
1981	9	3	795	Anti-hypertensive Effects of Bunitrolol －A Multi-Clinical Double-blind Comparison with Propranolol－	Kikuo Arakawa	Masayuki Tsuchiya	et al.
1982	10	1	19	Clinical Effects of Oxprenolol in Essential Hypertension －Multi-center Double-blind Study in Comparison with Reserpine－	et al.	(Research Group for OXPRENOLOL)
1982	10	1	45	Clinical Effects of Oxprenolol in Essential Hypertension －Multi-center Double-blind Study in Comparison with Pindolol－	et al.	（Research Group for OXPRENOLOL）
1982	10	1	73	Clinical Effect of Guanfacine, A Centrally Acting Antihypertensive Drug Alone on Essential Hypertension －Double-Blind Inter-group Comparative Study with α-Methyldopa as Referance Drug－	Hiroshi Ashizawa	Hyoe Ishikawa	et al.
1982	10	1	97	A Comparative Double-Blind Study of Alprazolam, Diazepam and Placebo in Neurosis	Ryo Takahashi	Yoshibumi Nakane	et al.
1982	10	1	117	A Double-Blind Study on the Clinical Effects of Bromazepam in the Disease of Circulatory System	Toshitsugu Ishikawa	Toyozo Aizawa	et al.
1982	10	1	149	Effect of Mepitiostane on Nephrogenic Anemia －A double-blind controlled study－	Shozo Koshikawa	Yoshio Suzuki	et al.
1982	10	1	175	Clinical Evaluation of Cefadroxil in the Treatment of Superficial Suppurative Skin and Soft Tissue Infections －A Double-blind Study Comparing to L-Cephalexin－	Eiichiro Nonami	Hisasi Takahashi	et al.
1982	10	1	201	A Study of Extra-normal Validity in the Rating List for Evaluating Abnormal Behaviors in Children	Eiko Kurisu	Yorio Satoh
1982	10	2	237	Evaluation of Active Drug and Inactive Placebo on Cerebrovascular Diseases in Chronic Stages －An analysis of 2,441 patients with double blind controlled studies－
1982	10	2	247	A Multi-Clinic Double-Blind Controlled Study on the Clinical Efficacy of Nomifensine and Imipramine in Depression	Takuro Noguchi	Reiichi Inoue	et al.
1982	10	2	277	Comparison of Clinical Effects of MS-4101(Flutazolam) and Diazepam on Neurosis －Multi-Center Double-Blind Controlled Study－	Masami Saito	Toshiaki Sakai	et al.
1982	10	2	303	Effect of Captopril (CS-522), an Angiotensin Converting Enzyme Inhibitor in Severe Hypertension －A Controlled Comparative Study with Hydralazine－	et al.	(Study Group for CS-522)
1982	10	2	347	A Double-Blind Controlled Clinical Study of Benoxaprofen in the Patient with Lumbago, Cervicobrachial Syndrome, or Pertiarthritis Scapulohumeralis	Torakichi Aoki	Makoto Yamamoto	et al.
1982	10	2	377	Effect of Mepitiostane on Aplastic Anemia －A Double-Blind Controlled Study－	et al.	(Study Group for Mepitiostane)
1982	10	2	393	Effects on Intraocular Pressure and Clinical Evaluation for the Usefulness of DE-016 Ophthalmic Solution (1)－Double-Blind Group Comparative Study－	Yoshiaki Kitazawa	Shigetoshi Nagataki
1982	10	2	429	Effects on Intraocular Pressure and Clinical Evaluation for the Usefulness of DE-016 Ophthalmic Solution (2)－Double-Blind Cross-Over Study－	Yoshiaki Kitazawa	Shigetoshi Nagataki	et al.
1982	10	2	469	Clinical Evaluation of Befunolol in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension under Controlled with Pilocarpine－Multi-Center Double Blind Study in Comparing Between Three Masked Dosages－	et al.	Cooperation Study Group on Clinical Evalutation of Befunolol
1982	10	2	515	Serum Dopamine-β-hydroxylase Levels and Efficacy of Fusaric Acid in Tardive Dyskinesia	Yoshiki Nakano	Yasuhiko Kawachi	et al.
1982	10	3	541	Clinical Evaluation of KW-3149 in the Treatment of Cerebrovascular Disorders－Multi-Center Double-Blind Study in Comparison with Cinnarizine－	Goro Araki	Ryuichi Kodama	et al.
1982	10	3	575	Clinical Evaluation of Timorol(Blocadren), on Essential Hypertension－Doublr-blind Comparison with Pindolol－	Tadanao Takeda	Nagao Kajiwara	et al.
1982	10	3	611	Effectiveness of Timolol (MK-950) on Arrhythmia －Double Blind Trial in Comparison with Pindolol Using Holter Monitor－	Hirofumi Osada	Kizuku Kuramoto	et al.
1982	10	3	643	Comparison of Clinical Effect on Neurosis of Clobazam, Diazepam and Placebo Using Double-Blind Techinique	Hiroshi Amamoto	Reiichi Inoue	et al.
1982	10	3	679	A Double-Blind Controlled Study of Clobazam	Hikaru Araki	Katsumi Isoda	et al.
1982	10	3	709	A Double-Blind Study of Viloxazine and Imipramine in Depression	Michio Okada	Takuro Noguchi	et al.
1982	10	3	737	Clinical Evaluation of HC 20-511(Ketotifen), a New Oral Anti-Anaphylatic Compound, in Bronchial Asthma－Ⅱ.Multi-Center Double-Blind Study in Comparison with Disodium Cromoglycate－	et al.	(HC20-511 Research Group)
1982	10	3	787	Clinical Evaluation of the Efficacy of Cetraxate on Acute Gastric Mucosal Lesions －Endoscopic Study by Multi-Center Double-Blind Method－	Shizo Ichioka	Takeshi Miwa	et al.
1983	11	1	13	Phase Ⅰ Study on Lysyl-Plasminogen Derived from Human Placenta (KB-623)－Ⅰ.Studies on Single-and Multiple-dose Administration－	Mutsuyoshi Kazama	Tadatoshi Kinoshita	et al.
1983	11	1	33	Phase Ⅰ Study on Lysyl-Plasminogen Derived from Human Placenta (KB-623)－Ⅱ	Mutsuyoshi Kazama	Tadatoshi Kinoshita	et al.
1983	11	1	51	Double-Blind Randomized Control Study with Gliclazide	Shoichi Nakagawa	Kazuo Takebe	et al.
1983	11	1	95	Double-Blind Randomized Control Study with Gliclazide	Fumiko Matsuda	Yasuo Sugita
1983	11	1	101	Double-Blind Study on the Clinical Effect of Minatol-P in the Treatment of Chronic Paranasal Sinusitis	Shozo Kawamura	Yoshio Yamazaki	et al.
1983	11	1	133	Clinical Evaluation of Norfloxacin in the Treatment of Superficial Suppurative Skin and Soft Tissue Infections－A Double-blind Study in Comparison with L-Cephalexin－	Eiichiro Nonami	Hisashi Takahashi	et al.
1983	11	1	155	Comparison of Clinical Effect on Obsessive-compulsive Neurosis of Bromazepam, Diazepam, Pephenazine, Trimipramine and Placebo Using Double-Blind Cross-Over Techinique	Kozo Itoh	Masaomi Endo	et al.
1983	11	1	201	Comparison of Clinical Effect on Depression of Dosulepin and Amitriptyline Using Double-Blind Technique	Masanao Kurihara	Sadanori Miura	et al.
1983	11	1	229	Pre-Treatment Prediction of Final Outcome of Depressive Patients under Antidepressant Therapy	masanao Kurihara
1983	11	2	265	Phase Ⅰ Study of YM-09151-2 (New Benzamide Derivative)	Kurefu Okamoto	Akihiko Takahashi	Sadanori Miura
1983	11	2	339	Clinical Utility of BV 26-723 (Brovincamine) in Treatment of Cerebrovascular Disorder－Multi-center Double-blind Study in Comparison with Ifenprodil Tartrate－	et al.	(Clinical Research Group for BV 26-723)
1983	11	2	389	Clinical Evaluation of EG 626 (Phthalazinol) in Central Pain and Allied Dysesthesia due to Cerebrovascular Disorders－Multi-clinical Double-blind Study in Comparison with Placebo－	Eiichi Otomo	Kazuya Ando	et al.
1983	11	2	429	Effects of Melinamide on Hyperlipidemia and Electrocardiogram－Clinical Evaluation by Double-Blind Comparative Study－	et al.	(Research Group for Melinamide)
1983	11	2	461	Clinical Evaluation of Diflunisal in the Treatment of Osteoarthritis of the Knee－A Double-Blind Conparative Study－	Takuro Sugano	Makoto Yamamoto	et al.
1983	11	2	489	Double-Blind Controlled Study on the Clinical Efficacy of Oral Etretinate in Psoriasis	et al.	(Clinical Research Group for Oral Etretinate)
1983	11	2	511	Double-Blind Clinical Evaluation of Miconazole Vaginal Tablets in the Treatment of Vulvovaginal Candidiasis	Akimitsu Hagiwara	Seiji Matsuda	et al.
1983	11	3	555	Clinical Utility of M-101 (moxisylyte) in Treatment of Cerebrovascular Disorders－Multi-center Double-blind Study in Comparison with Ifenprodil (tartrate)－	et al.	Cooperation Study Group on Clinical Evaluation of M-101
1983	11	3	591	Clinical Evaluation of Arotinolol (S-596) for Angina pectoris－A Double Blinded Comparative Study with Propranolol－	Tomohiro Kanazawa	Kazuzo Kato	et al.
1983	11	3	623	Anti-Arrhythmic Effects of Arotinolol on Premature Ventricular Contraction －A Multicenter Double Blind Control Study by Comparison with Propranolol－	Seiichi Toyama	Noboru yamazaki	et al.
1983	11	3	649	Clinical Usefulness of Probucol in Hyperlipidemia －A Three-way Parallel Double-Blind Controlled Study－	Tadao Yasugi	Haruo Nakamura	et al.
1983	11	3	681	Clinical Evaluation of Flutoprazepam (KB-509), Once-a-day Administration, on Psychosomatic Disorders, Neuroses and Depressive States－A Double-Blind Controlled Study Using Lorazepam as a Standard Drug－	Tetsuya Nakagawa	Ken Fukamachi	et al.
1983	11	3	721	Clinical Evaluation of N-acetyl-L-cysteine(TY-0048) in Patients with Difficulty in Sputum Expectration －A Double-blind Comparative Study with Mecysteine Hydrochloride Acid Tablet and Placebo Control－	Shigeru Nagaoka	Humio Nagahama	et al.
1983	11	3	743	Phase Ⅰ Study on at pH 4 Treated Human Immunogloblin (IG-100)	Mutsuyochi Kazama	Tadatoshi Kinoshita	et al.
1983	11	3	763	Phase Ⅰ Study of Oral Urokinase (ZP-201) －Ⅰ. Single Dose Study－	Mutsuyoshi Kazama	Tadatoshi Kinoshita	et al.
1983	11	3	781	Phase Ⅰ Study of Oral Urokinase (ZP-201) －Ⅱ. Multiple Dose Study－	Mutsuyoshi Kazama	Tadatoshi Kinoshita	et al.
1984	12	1	15	Phase Ⅰ Study of KTH-497, A New Benzodiazepine Derivative	Yoshio Kudo	Yukio Kawakita	Osamu Shimada
1984	12	1	43	Double-Blind Comparison of Clinical Effects of Flutoprazepam (KB-509) and Diazepam on Psychoneuroses	Kenjiro Miyamoto	Setsuo Mizushima	et al.
1984	12	1	81	Clinical Evalutaion of L-5HTP in Depression －Multi-center double-blind study in parallel comparison with imipramine－	et al.	(Study Group for KS-5)
1984	12	1	137	A Multi-center Double-Blind Trial of Tiapride and Placebo in the Treatment of Dyskinesia in Patients with and without Parkinsonism	et al.	(Study Group for Tiapride)
1984	12	1	195	Clinical Evaluation of γ-Oryzanol(Hi-Z) in Hyperlipidemia －A Muticenter Double-blind Trial－	Toshitsugu Oda	Hideo Miyashita	et al.
1984	12	1	231	Clinical Evaluation of E-0646 (Eperisone Hydrochloride) on Cervicobrachial Syndrome, Periarthritis Scapulohumeralis and Lumbago－A Double-Blind Controlled Study－	Yasuhiro Hatsuyama	Ryuichi Nihei	et al.
1984	12	1	275	Clinical Evaluation of Indomethacin Cataplasm (IM-P) in the Orthopaedic Field－A Double-Blind Cross-Over Study with the Inactive Placebo－	Yoshio Komatsubara	Masami Kimura	Masaki Tsujimoto
1984	12	2	321	Clinical Evaluation of Amantadine hydrochloride (Symmetrel) in the Treatment of Cerebrovascular Disorders with Psychiatric Symptoms－Multi-center double-blind study in comparison with placebo－	et al.	(Study Group for Symmetrel Clinical Evaluation)
1984	12	2	369	Clinical Utility of Bromocriptine in Parkinsonian Syndrome －Multi-Centeric Investigation in Comparison with Amantadine Hydrochloride by Double Blind Method－	Makoto Iwata	Masao Kase	et al.
1984	12	2	403	Therapeutic Effect of Bromocriptine in Parkinsonian Syndrome－Combined Therapy with Levodopa in Comparison Between Bromocriptine and Placebo by Double Blind Method－	Yoshikuni Mizuno	Masao Kase	et al.
1984	12	2	445	Clinical Evaluation of KSP-117 (sustained release preparation of amitriptyline) on Depressive Patients－A double-blind comparison with amitriptyline－	Hitoshi Itoh	Atsuyoshi Mori	et al.
1984	12	2	475	Clinical Evaluation of Traxanox Sodium (Y-12141), a New Oral Anti-Allergic Compound, in Bronchial Asthma －Multi-Center Double-Blind Study in comparison with DSCG and Placebo－	et al.	(Traxanox Study Group)
1984	12	3	611	Clinical Investigation of Antihypertensive Efficacy of Artinolol Used Alone or in Combination with Thiazide Diuretics in Essential Hypertension －Double-blind, Comparative Study with Propranolol－	Yoshiaki Inagaki	Nagao Kajiwara	et al.
1984	12	3	647	Evaluation of Therapeutic Effects of Formoterol, A β-receptor Stimulating Bronchodilator, on Bronchial Asthma－A Joint Double-blind Single-dose Study at 30 Institutions (Part 1)－	et al.	(Formoterol Research Group)
1984	12	3	671	Evaluation of Therapeutic Effects of Formoterol, A β-receptor Stimulatinf Bronchodilator, on Bronchial Asthma－A Joint Double-blind Single-dose Study at 37 Institutions (Part 2)－	et al.	(Formoterol Research Group)
1984	12	3	697	Evaluation of Therapeutic Effects of Formoterol, A New β-receptor Stimulating Bronchodilator, on Bronchial Asthma－A Joint Double-blind Repeated-dose Study at 37 Instisutions－	et al.	(Formoterol Research Group)
1984	12	3	729	A Double-Blind Controlled Clinical Study of Oxaprozin in the Patient with Lumbago, Cervicobrachial Syndrome and Periarthritis Scapulohumeralis	Mitsuo Hasue	Tetsuya Hara	Ryuichi Nihei
1984	12	3	765	A Double-Blind Controlled Study of Camazepam	Seiichi Ichimaru	Tsuyoshi Nishimura	et al.
1984	12	3	775	The New Assessment Method of Drug Dependency	et al.
1984	12	3	827	Problems of the Repeated Use of Statistical Tests on Many Response Items and for Multiple Stratification	Hiroe Tsubaki	Yorio Satoh	Masanao Kurihara	Satoshi Fujimoto
1985	13	1	19	Effectiveness of Zopiclone (27 267 R.P.) in Insomnia －Multi-center Double-blind Study in Comparison with Flurazepam－	et al.	(Hokkaido Clinical Psycho-Pharmacological Association)
1985	13	1	53	Clinical Evaluation of Nomifensine on Antidepressant Effects Using Double-Blind Comparative Technique with Imipramine	Yoshio Kudo	Shosuke Watanabe	et al.
1985	13	1	105	Clinical Evaluation of Bromperidol, a new investigational Butyrophenone Derivative, in Schizophrenia, A Double-blind Comparison of Bromperidol and haloperidol	Hidenori Anno	Yasuo Fujii	et al.
1985	13	1	137	Comparison of Clinical Effect on Vegetative Dystonia of OK-O-05, Oryzanol and Placebo Using Double-Blind Technique	Tomonobu Kawano	Taisaku Katsura	et al.
1985	13	1	169	Endoscopic Evaluation of the Clinical Efficacy of Gefarnate on Acute Gastric Mucosal Lesions－A Comparative Double-Blind Study with Cetraxate and Placebo－	Noboru Watanabe	Shisyo Ichioka	et al.
1985	13	1	195	Clinical Evaluation of Liposteroid in the Treatment of Rheumatoid Arthritis, A Double-Blind Comparison with Decardron	Takamasa Kageyama	Yutaka Mizushima	et al.
1985	13	1	229	Clinical Evaluation of MEN-OM in the Treatment of Osteoarthritis of the Knee －A Double-Blind Comparative Study－	Chihiro Kimura	Katsumi Suzuki	et al.
1985	13	1	257	Phase Ⅰ Study of a New Synthetic Platelet Aggregation Suppressant OPC-13013 (6-[4-(1-Cyclohexyl-1H-Tetrazole-5yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone)	Mutsuyoshi Kazama	Tadatoshi Kinoshita	et al.
1985	13	2	295	Clinical Usefulness of Tiapride on Psychiatric Symptoms Caused by Cerebrovascular Disorders －A Multi-center Double-Blind Study in Comparison with Inactive Placebo－	et al.	(Study Group for Tiapride)
1985	13	2	333	Clinical Evaluation of MK-421 (Enalapril Maleate) in the Treatment of Severe Hypertension －A Comparative Study with Captopril－	et al.	(MK-421 Study Group)
1985	13	2	381	Clinical Evaluation of Medroxyprogesterone Acetate in Advanced Breast Cancer－A Double-Blind Controlled Trial with Mepitiostane－	et al.	(Japanese Group for MPA Treatment of Breast Cancer)
1985	13	2	419	Clinical Evaluation of an Anorexiant Mazindol in the Trearment of Obesity－Multi-Center Open Trial in Phase Ⅱ－	Masakazu Abe	Akira Kumagai	et al.
1985	13	2	461	Clinical Evaluation of Mazindol, an Anorexiant, on Obesity －Multi-Center Double-Blind Study in Comparison with Placebo－	Akira Kumagai	Yuichiro Goto	et al.
1985	13	2	517	A Study of the Problem of Dependency of Mazindol －A Clinical Open Study－	et al.	(Mazindol Dependency Study Group)
1985	13	2	549	Phase Ⅰ Study of Haloperidol Decanoate	Yukio Kawakita	Seiichi Ichimaru	et al.
1985	13	3	613	Clinical Evaluation of MK-421 (Enalapril Maleate), an Angiotensin-Converting Enzyme Inhibitor, Used Alone as Treatment of Essential Hypertension－Results of Double-Blind Group Comparison Study with Captopril as Control Drug－	et al.	(Results of Double-Blind Group Comparison Study with Captopril as Control Drug－
1985	13	3	659	Clinical Utility of Urokinase in the Treatment of Acute Stage of Cerebral Thrombosis－Multi-center Double-Blind Study in Comparison with Placebo－	et al.	(UK-BR Study Group)
1985	13	3	711	Clinical Efficacy of Urokinase in the Treatment of Cerebral Thrombosis －Multi-center Double-Blind Study in Comparison with Placebo－	Goro Araki	Eiichi Itoh	et al.
1985	13	3	753	A Multicenter Double-Blind Trial of Tiapride and Placebo in the Treatment of Tardive Dyskinesia	Gohei Yagi	Kunitoshi Kamishima	et al.
1985	13	3	791	Clinical Evaluation of Eptazocnine on Postoperative Pain －A Double-Blind Study in Comparison with Pentazocine－	et al.	(Study Group for Eptazocine)
1985	13	3	813	Phase Ⅰ Study of Bromperidol	Kurefu Okamoto	Akihiko Takahashi	et al.
1986	14	1	13	Clinical Evaluation of OPC-13013, a New Platelet Aggregation Inhibitor, on Chronic Arterial Occlusive Diseases－Dose Finding Study by Double-Blind Method－	Tatsuzo Tanabe	Keishu Yasuda	et al.
1986	14	1	43	Clinical Investigation of Tizanidine (DS 103-282) on Cerebral and Spinal Paralyses －Multicentric Double-Blind Study－	Itsuro Sobue	Yasuo Toyokura	et al.
1986	14	1	77	Effectiveness of Zopiclone (27 267 R.P.) in Insomnia －Multi-center Double-Blind Study in Comparison with Flurazepam－(The second report)	et al.	(Hokkaido Clinical Psycho-Pharmacological Association)
1986	14	1	109	Clinical Evaluation of Lormetazepam (WY-4082) on Insomnia in Neuropsychiatric Field－A Multiclinical Double-Blind Comparison with Flurazepam－	Kunitoshi Kamishima	Hiroshi Hada	et al.
1986	14	1	133	Clinical Evaluation of BL 191 RD (Pentoxifylline Retarded Formulation), Pentoxifylline and Dilazep hydrochloride in the Treatmetnt of Cerebrovascular Disorders－A Double-Blind Controlled Study－	Hideo Tohgi	Kyuya Kogure	et al.
1986	14	1	175	Clinical Evaluation of Ceruletide in Schizophrenia －Multi-institutional double-blind placebo controlled study－	et al.	(Study Group for CLN)
1986	14	2	231	Phase Ⅰ Study of Quinupramine (LM-208) A New Iminodibenzyl Derivative	Yoshio Kudo	Seiichi Ichimaru	Osamu Shimada
1986	14	2	249	Clinical Evaluation of Afloqualone on Cervicobrachial Syndrome and Lumbago －A Double-blind Controlled Trial－	Yasuhiro Hatsuyama	Takahide Kurokawa	et al.
1986	14	2	279	Clinical Evaluation of LS-121 in the Treatment of Cerebrovascular Disorders －Multi-center double-blind study in comparison with Nicardipine－	Takashi Kutsuzawa	Goro Araki	et al.
1986	14	2	343	Clinical Evaluation of KC-404 in the Treatment of Cerebrovascular Disorders －Multi-Center Double-blind Study in Comparison with Nicardipine Hydrochloride－	Tsuneo Hasegawa	Eiichi Ohtomo	et al.
1986	14	2	373	Clinical Evaluation of KC-404, a New Anti-asthmatic Agent, in the Treatment of Bronchial Asthma－Multi-center Double-blind Study in Comparison with Tranilast－	et al.	(KC-404 Study Group)
1986	14	2	409	Clinical Evaluation of Sultopride Schizophrenic Patients In A Double-Blind Comparison With Haloperidol	Mitsukuni Murasaki	Kunitoshi Kamijima	et al.
1986	14	2	437	Ciclosporin Treatment for Behcet's Disease －Double-Masked Group Comparative Study－	Akira Nakajima	Akira Urayama	et al.
1986	14	3	487	Phase Ⅰ Study of Y-516 (A New Iminodibenzyl Compound)	Mitsukuni Murasaki	Hirofumi Wakatabe	et al.
1986	14	3	525	Clinical Efficacy of HWA 285 in the Treatment of Cerebrovascular Disorders －Multi-center double-blind study in comparison with calcium hopantenate－	Goro Araki	Eiichi Itho	et al.
1986	14	3	575	Clinical Evaluation of TA-079 (Nicergoline) in the Treatment of Cerebrovascular Disorders－Multi-center double-blind study in comparison with Ca-hopantenate－	Shunsaku Hirai	Kazuo Hasegawa	et al.
1986	14	3	603	Comparison of Therapeutic Efficacy on Neurosis between CM6912 (ethyl loflazepate) and Diazepam in a Double-blind Trial	Atsuyoshi Mori	Takuro Noguchi	et al.
1986	14	3	643	Clinical Evaluation of Ethyl Loflazepate (CM6912), Once-a-day Administration, on Psychosomatic Diseases and Neuroses －A Double-Blind Controlled Study Using Lorazepam－	Tetsuya nakagawa	Ken Fukamachi	et al.
1986	14	3	683	A Multicenter Clinical Evaluation of Y-8894 in Depression	Hitoshi Itoh	Atsuyoshi Mori	et al.
1986	14	4	723	Clinical Evaluation of EB-382 in the Treatment of Osteoarthritis of the Knee －A Double-Blind Comparative Study－	Takamasa Kageyama	Sachiko Sugawara	et al.
1986	14	4	757	Clinical Evaluation of Misoprostol (SC-29333) in the Treatment of Gastric Ulcer － A Multicenter Double-Blind Comparative Study with Cetraxate Hydrochloride－	Takashi Nakamura	Makoto Ishikawa	et al.
1986	14	4	793	Clinical Evaluation of Misoprostol (SC-29333) in the Treatment of Duodenal Ulcer － A Multicenter Double-Blind Comparative Study with Cimetidine－	Takashi Nakamura	Makoto Ishikawa	et al.
1986	14	4	827	Effects of Org DD-100 (Nandrolone decanoate) on Renal Anemia －A Multi-center Double-Blind Study－	Shozo Koshikawa	Toshiaki Suzuki	et al.
1986	14	4	859	The Clinical Efficacy of Cepharanthin 60mg/day in Cutaneous Amyloidosis －Double-Blind Controlled Study in Comparison with Cepharanthin 6mg/day－	Fumio Kaneko	Masaru Ohhashi	et al.
1986	14	4	879	Double-Blind Controlled Trial of Coenzyme A Injection in the Treatment of Fatty Liver	et al.	(Study Group for Fatty Liver)
1986	14	4	893	The Evaluation Method of Clinical Effects of Drug for Fatty Liver －Judgement of histological findings of the liver and variations of blood biochemical values from different labo-centers－	et al.	(Study Group for Fatty Liver)
1987	15	1	15	Comparison of Therapeutic Effect on Mania of Sultopride Hydrochloride with Haloperidol using Double-Blind Technique	Seiichi Ichimaru	Yukio Kawakita	et al.
1987	15	1	37	A Phase Ⅲ Study of KD-136 (Haloperidol Decanoate: A Lond-Acting Neuroleptic) in the Treatment of Schizophrenia －The Detailed Analysis of Multi-Clinical Double-Blind Comparative Study of Haloperidol Decanoate with Oral Haloperidol Preparation－	et al.	(Study Group for KD-136)
1987	15	1	73	Clinical Effect of Nipradiol (K-351) in Combined Therapy with Thiazide Diuretic on Essential Hypertension －A Multi-central Double-blind Comparison with Propranolol －	Yoshihiro Kaneko	Kiyoshi Kuramoto	et al.
1987	15	1	107	Clinical Evaluation of LS-121 Injection in the Treatment of Cerebral Infarction and Cerebral Hemorrhage in Acute and Subacute Stages －Multi-center double-blind study with placebo as the control drug－	Kenji Nakajima	Goro Araki	et al.
1987	15	1	143	Clinical Utility of OPC-13013 in Treatment of Cerebrovascular Disorders－Multi-center double-blind study－	Shunsaku Hirai	Goro Araki	et al.
1987	15	1	181	Clinical Evaluation of Rilmazafone (450191-S), a New Hypnotic, in the Treatment on Insomnia in Neuropsychiatric Field－Multi-center, Double-blind, Cross-over Trial for the Comparison with Trizolam－	Toshihiko Kinoshita	Hidetoshi Miyamoto	et al.
1987	15	2	233	Comparison of Therapeutic Effect on Excitement State of Schizophrenia and Atypical Psychosis of Sultopride Hydrochloride with Haloperidol using Double-Blind Technique	Seiichi Ichimaru	Yukio Kawakita	et al.
1987	15	2	253	Clinical Efficacy of Bunitrolol Retard (Ko 1366 PL) in the Treatment of Essential Hypertension－Multi-center double-blind study in comparison with bunitrolol (Betrilol)	Yoshiaki Masuyama	Ichiro Nishio	et al.
1987	15	2	283	Clinical Investigation of Effects and Safety of Bunitrolol Slow-Releasing Agent (Ko1366PL) on Essential Hypertension －A Multi-Institutional Double-Blind Comparison by Fixed-Flexible Method－	Keishi Abe	Yukio Miura	et al.
1987	15	2	307	Clinical Evaluation of TM-906 (Trimebutine Maleate) in the Treatment of Irritable Bowel Syndrome －Multi-center double-blind study in comparison with Mepenzolate bromide－	Akima Miyoshi	Kiyoshi Kawakami	et al.
1987	15	2	335	Phase Ⅰ Study of a New Antianxiety Drug, Buspirone	Jun Ishigooka	Akihiko Takahashi	et al.
1987	15	2	371	Clinical Evaluation of RU 39780 (Binedaline Hydrochloride) on Depression and Depressive States －The Double-Blind Group Comparative Study with the Control of Imipramine－	Hitoshi Itoh	Atsuyoshi Mori	et al.
1987	15	2	381	Influence of Ca-Hopantenate on Laboratory Values－Particularly in mentally retarded children－	Koichiro Shirahashi	Masashi Takesada	et al.
1987	15	3	423	Therapeutic Effects of L-DOPS in Parkinson's Disease －Double-blind, comparative study against placebo as control in patients with the long-term levodopa therapy－	Takao Nakanishi	Mitsuo Yoshida	et al.
1987	15	3	459	A Randomaized, Double Blind Controlled Study for 7 days on the Efficacy of Human Lymphoblastoid Interferon (HLBI) for Chronic Hepatitis B virus Infections	Takashi Matsushima	Shiro Iino	et al.
1987	15	3	487	Clinical Evaluation of AST-120 in the Treatment of Chronic Renal Failure －Multi-center, double-blind study in comparison with placebo－	Shozo Koshikawa	Yoshiji Yamane	et al.
1987	15	3	527	Clinical Evaluation of AST-120 on Suppression of Progression of Chronic Renal Failure －Multi-center, double-blind study in comparison with placebo－	Shozo Koshikawa	Yoshiji Yamane	et al.
1987	15	3	565	Clinical Evaluation of Temazepam on Insomnia in Neuropsychiatric Field (Except for Schizophrenic Insomnia) － Comparative Double-Blind Study with Nitrazepam－	Sadanori Miura	Mitsuaki Inami	et al.
1987	15	3	577	Phase Ⅰ Study of Norfloxacin Ophthalmic Solution	Machiko Abe
1988	16	1	25	Therapeutic Effect of Ea-0671 on Acute Gastritis and Acute Exacerbation in Chronic Gastritis －Multicenter Double-Blind Controlled Study Compared with Cetraxate, Mainly Using Endoscopic Evaluation－	Shinroku Ashizawa	Kazuhiko Iwakoshi	et al.
1988	16	1	49	Study on the Efficacy of Mianserin Hydrochloride －A double-blind comparative trial between a single night-time and divided daily dose regimen－
1988	16	1	81	Clinical Evaluation of FUT-175, a Regional Anti-coagulant for Hemodialysis Patients with Hemorrhagic Complications －Multi-center comparative study with Heparin－	Tadao Akizawa	Yoshihei Hirasawa	et al.
1988	16	1	115	Comparison of Anti-Manic Efficacy of Carbamazepine and Lithium Carbonate by Double-Blind Controlled Study	Itaru Yamashita	Ryo Takahashi	et al.
1988	16	1	149	Phase Ⅰ Study of OPC-4392	Jun Ishigooka	Akihiko Takahashi	et al.
1988	16	2	211	Clinical Evaluation of CS-514 (Pravastatin) on Hyperlipidemia －Double-blind study with clinofibrate－
1988	16	2	251	Clinical Evaluation of Long-term Oral Administration of OPC-8212 in the Treatment of Chronic Heart Failure －A Multicenter Placebo-controlled Double-blind Trial－	Shigetake Sasayama	Michitoshi Inoue	et al.
1988	16	2	291	Clinical Evaluation of Y-8864 in the Treatment of Cerebrovascular Disorders －Multi-center double-blind study in comparison with Calcium hopantenate－	Hiroshi Sekimoto	Eiichi Itoh	et al.
1988	16	2	327	Comparison of the Therapeutic Effect of Carbamazepine and Placebo in Schizophrenia and Atypical Psychosis by Double-Blind Controlled Study	Itaru Yamashita	Ryo Takahashi	et al.
1988	16	2	375	A Double-Blind Controlled Study of CM 6912 (Ethyl loflazepate) on Neurosis Using Placebo	Atsuyoshi Mori	Kenshiro Ohara	et al.
1988	16	3	425	Clinical Utility of HYG-FAS in Treatment of Cerebrovascular Disorders －Multi-Center Double-Blind Study in Comparison with Hydergine Tablet 2mg－	Eiichi Ohtomo	et al.(Clinical Research Study Group for HYG-FAS)
1988	16	3	487	Futher Analysis of the Phase Ⅲ Comparative Study of KD-136 (Haloperidol Decanoate: A Long-Acting Injectable Neuroleptic) and Oral Haloperidol in the Treatment of Chronic Schizophrenia	Masanao Kurihara	et al.(Study Group for KD-136)
1988	16	3	499	Clinical Assessment of Gestrinone (R 2323) in Patients with Endometriosis －Multi-center double-blind study in comparison with Danazol－	et al.(Study Group for R 2323)
1988	16	3	547	Phase Ⅰ Study of KRN5702 (recombinant human erythropoietin)	Munehito Kumagae	Sachiko Itoh	et al.
1988	16	4	581	A Double-blind study of EHDP on Heterotopic Ossification after Spinal Cord Injury Using Placebo	Kiyoshi Kaneda	Kunio Takaoka	et al.
1988	16	4	617	Usefulness and Determination of Optimal Dose of Misoprostol in the Treatment of Gastritis in a Double-Blind Study	Takashi Nakamura	Makoto Ishikawa	et al.
1988	16	4	643	Dose Finding Trial of Cibenzoline in Patients with Venticular Premature Contraction using Double-blind Technique in a Multi-center Cooperation	Hiroyuki Iinuma	Takahisa Tanabe	et al.
1988	16	4	661	Clinical Evaluation of Lormetazepam in the Treatment of Sleep Disturbances (First Report) －Double-blind Trial in Comparison with Nitrazepam－	Sadanori Miura	Itaru Yamashita	et al.
1988	16	4	687	Clinical Evaluation of Lormetazepam in the Treatment of Sleep Disturbances (Second Report) －Correction of Background Bias－	Jungo Sawa
1989	17	1	11	Clinical Efficacy and Safety of Cibenzoline in Patients with Ventricular Premature Contraction －A Double-blind Group Comparative Trial in Comparison with Disopyramide in a Multi-center Cooperation－	Hiroyuki Iinuma	Saichi Hosoda	et al.
1989	17	1	35	Clinical Efficacy and Safety of Cibenzoline in Patients with Supraventricular Premature Contraction －A Double-blind Group Comparative Trial in Comparison with Disopyramide in a Multicenter Cooperation－	Hiroyuki Iinuma	Saichi Hosoda	et al.
1989	17	1	57	Clinical Effects of Bepridil (Org 5730) on Premature Ventricular Contraction －A Multicenter Group Comparative Double-blind Study －	Hirokazu Hayakawa	Hirofumi Osada	et al.
1989	17	1	77	Clinical Evaluation of E-0659 on Atopic Dermatitis －Multicenter Double-blind Study in Comparison with Ketotifen－
1989	17	1	117	Dose-Response and Duration of Betaxolol Ophthalmic Solution on Primary Open Angle Glaucoma and Ocular Hypertension －Double-Masked Cross-Over Study－	Ikuro Azuma	Makoto Araie
1989	17	2	177	A Double-blind Comparison of a New Iminodibenzyl Compound Y-516 with Clocapramine in the Pharmacotherapy of Schizophrenia	Ryo Takahashi	Gohei Yagi	et al.
1989	17	2	197	A Multicenter Double-Blind Comparative Study of 4-Week Duration on Effect of Bepridil (Org 5730) in Ventricular Premature Contraction	Hiroshi Kasanuki	Hirokazu Hayakawa	et al.
1989	17	2	219	Clinical Evaluation of Flecainide Acetate in the Treatment of Ventricular and Atrial Premature Contractions －Multicenter Double-Blind Study Using Disopyramide－	Yasuro Nakata	Hiroyuki Iinuma	et al.
1989	17	2	243	Clinical Evaluation of Betaxolol Hydrochloride in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension －Multi-Center Double-Masked Study in Comparison with Timolol－	et al.
1989	17	2	275	Clinical Effect of Ketotifen Ophthalmic Solution on Allergic Conjunctivitis and Vernal Conjunctivitis －Multi-center Double-blind Study in Comparison with Disodium Cromoglycate Ophthalmic Soluaion －	Akira Nakajima	Fumio Kogure	et al.
1989	17	2	299	Clinical Evaluation of TD 2-01 in Maintenance Fluid Therapy －Multi-center Double-blind Study in Comparison with 10% EL-3－	Teiryo Maeda	Goro Oya	et al.
1989	17	3,4	349	A Double-Blind Comparison of a New Benzamide Compound YM-09151 with Haloperidol in the Treatment of Schizophrenia	Hajime Kazamatsuri	Shigeru Kaneno	et al.
1989	17	3,4	379	Clinical Evaluation of Quinupramine (LM-208) on Depression and Depressive State in a Multi-center Cooperation	Seiichi Ichimaru	Yukio Kawakita	et al.
1989	17	3,4	403	Clinical Evaluation of Quinupramine (LM-208) on Depression and Depressive States －DB study with Imipramine hydrochloride－	Seiichi Ichimaru	Yukio Kawakita	et al.
1989	17	3,4	413	A Multicenter Double-Blind Comparative Study on Effect of Bepridil (Org 5730) in Supraventricular Premature Contraction	Takahisa Tanabe	Hirokazu Hayakawa	et al.
1989	17	3,4	429	Clinical Evaluation of Bepridil (Org 5730) on Angina pectoris －Multicenter Double-blind Study in Comparison with Nifedipine－	Saichi Hosoda	Hirokazu Hayakawa	et al.
1989	17	3,4	451	A Double-blind, Dose-finding Study of Recombinant Tissue-type Plasminogen Activator, SM-9527 for the Intravenous Thrombolysis in Acute Myocardial Infarction	Kiyoshi Machii	Nagao Kajiwara	et al.
1989	17	3,4	485	Clinical Usefulness of Intravenous Application of SM-9527 (duteplase; t-PA) in Acute Myocardial Infarction －A multicentered, double-blind comparative study with intravenous administration of urokinase－	Kiyoshi Machii	Nagao Kajiwara	et al.
1989	17	3,4	517	A Fetal Case of Acute Lithium Intoxication with Cardiomyopathy	Hajime Kanamura	Masanao Kurihara	et al.
1990	18	1	19	Clinical Efficacy of Bopindolol, a New β-blocker in Angina Pectoris －Multicenter Double-Blind Comparative Study－	Tomohiro Kanazawa	Norimitsu Takahashi	et al.
1990	18	1	39	Clinical Efficacy of Intravenous Administration of SM-9527 (t-PA) in Cerebrak Thrombosis －Multi-center double-blind study in comparison with urokinase－	Akiro Terashi	Hideo Tohgi	et al.
1990	18	1	71	Clinical Evaluation of Low Molecular Weight Heparin: LHG-500 －Phase Ⅰ Study: Single Dosage Test－	Kayoko Wakasugi	Chieko Tahara	et al.
1990	18	1	95	Clinical Evaluation of Low Molecular Weight Heparin: LHG-500 －Phase Ⅰ Study: Multiple Dosage Test－	Kayoko Wakasugi	Chieko Tahara	et al.
1990	18	1	121	Clinical Evaluation of NFG Ophthalmic Solution in the Treatment of Viral Conjunctivitis －Multi-center, double-blind study in comparison with placebo－	Shusaku Kitano	Yukio Uchida	et al.
1990	18	1	145	Clinical Evaluation of Quinupramine on Depression and Depressive State	Masanao Kurihara	Hitoshi Itoh	et al.
1990	18	2	251	Clinical Effectiveness of KB-831(trazodone hydrochloride), a New Antidepressant,on Depression－A clinical phase Ⅱ study by double-blind method－	Masanao Kurihara	Ryo Takahashi	et al.
1990	18	2	279	Clinical Effects of Trazodone (KB-831) on Depression－A double-blind comparative study using amitriptyline as a standard drug－	Masanao Kurihara	Ryo Takahashi
1990	18	2	315	Effects of Modified Release Bromocriptine on Parkinson's Disease and Parkinsonism, A Double-blind Study	Tohru Mannen	Makoto Iwata	et al.
1990	18	2	341	Double-Blind Study Evaluating the Efficacy of Parlodel Modified Release Capsule (PLO-MR) in the Suppression of Puerperal Lactation	Toshihiro Aono	Rihachi Iizuka	et al.
1990	18	2	357	Double-Blind Study Evaluating the Efficacy of Parlodel Modified Release Capsule (PLO-MR) in the Treatment of Prolactin-Related Disorders	Toshihiro Aono	Rihachi Iizuka	et al.
1990	18	3	433	Efficacy of a new anxiolytic, buspirone on neurosis－A comparative double-blind study with diazepam and placebo－	Mituskuni Murasaki	Shunkichi Endo	et al.
1990	18	3	455	Meclofenoxate Hydrochloride (Lucidril) in Tardive Dyskinesia－A Double-Blind Placebo-Controlled Sthdy－	Kunitoshi Kamishima	Sadanori Miura
1991	19	1	15	A Double-blind Comparative Study on the Efficacy and and Safety of Fluphenazine Decanoate (SQ 10, 733) and Oral Haloperidol in the Treatment of Schizophrenic Patients	Teruo Ohkuma	et al.(Study Group of FD)
1991	19	1	47	Clinical Evaluation of Pravastatin (CS-514) in Once Daily Therapy on Hyperlipidemia－Double-blind Comparative Study between Once Daily and Twice Daily Therapy－	Akira Yamamoto	Yuichiro Goto	et al.(Study Group of CS-514-10)
1991	19	1	93	Phase Ⅰ Study of Risperidone, a New Antipsychotic Drug of Benzisoxazol Derivative	Hirobumi Wakatabe	Mitsukuni Murasaki	et al.
1991	19	2	213	A Multicenter Double-blind Comparison Study of Amlodipine and Nicardipine-retard in Patients with Esseneial Hypertension	Mikio Arita	Osamu Iimura	et al.
1991	19	2	243	Clinical Evaluation of SIT-150, a Glucose Contained Bicarbonate Dialysate－Multi-center Comparative Study with a Glucose Free Dialysate－	Yoshihei Hirasawa	Kazuo Ota	Shozo Koshikawa	Yousuke Ogura	et al.
1991	19	2	267	Experimental Design and Analysis for Determination of Improvement Rating by Video Imaging－A Double-Blind Placebo-Controlled Study for Meclofenoxate Hydrochloride (Lucidril) in Tardive Dyskinesia－	Michiko Tsubaki	Gohei Yagi	et al.
1991	19	3	315	Clinical Utility of CT-848 (Oxiracetam) in the Treatment of Cerebral Infarction－A multi-center, double-blind study in comparison with Idebenone－	Hideo Togi	Shunsaku Hirai	et al.
1991	19	3	355	Clinical Efficacy of Amlodipine Besylate on Angina Pectoris－Multicenter Double-Blind Comparative Dose-Finding Study－	Hiroshi Kishida	Yotaro Oyama	et al.
1991	19	3	379	Clinical Evaluation of Amlodipine Besylate on Angina Pectoris－Multicenter Double-blind Comparative Study with Nifedipine Retard－	Yotaro Oyama	Seiichi Toyama	et al.
1991	19	3	405	Evaluation of the Quality of Life in Patients with Cerebrovascular Diseases	Hideyuki Sawada	Masakuni Kameyama
1991	19	4	439	Clinical Efficacy and Safety of Intravenous Cibenzoline in the Treatment of Patients with Ventricular Premature Contractions	Hiroyuki Iinuma	Hiroshi Inoue	et al.
1991	19	4	461	Clinical Evaluation of Intravenous Cibenzoline in Treatment of Paroxysmal Supraventricular Techycardia－A Multicenter Double-blind Study in Comparison with Placebo－	Hiroyuki Iinuma	Takahisa Tanabe	et al.
1991	19	4	477	Clinical Evaluation of Intravenous Cibenzoline in Treatment of Paroxysmal Atrial Fibrillation or Paroxysmal Atrial Flutter－A Multicenter Double-blind Study in Comparison with Placebo－	Hiroyuki Iinuma	Tsuneaki Sugimoto	et al.
1991	19	4	491	Effects of Single Bolus Injection of Low Molecular Weight Heparin (LHG-500) as an Anticoagulant for Hemodialysys－Double-Blind Cross-over Study in Comparison with Continuous Administration of Conventional Heparin－	Tadao Akizawa	Nobuhide Mimura	et al.
1991	19	4	541	Effects of LHG-500 (Low Molecular Weight Heparin) as an Anticoagulant for Hemodialysis Patients with Bleeding Risks－Multi-instirutional Control Study with Low Dose or Regional Heparinization－	Tadao Akizawa	Nobuhide Mimura	et al.
1992	20	1	11	Clinical Evaluation of Temocapril Hydrochloride (CS-622), an Angiotensin-Converting Enzyme Inhibitor, Used Alone for Treatment of Essential Hypertension－Results of Double-Blind Enalapril Maleate-Controlled Study－	Keishi Abe	Osamu Iimura	et al.
1992	20	1	45	Clinical Evaluation of Ea-0167 (Menatetrenone) in the Treatment of Osteoporosis－Phase Ⅲ Double-blind Multicenter Comparative Study with Alfacalcidol－	Masataka Shiraki	et al.
1992	20	1	101	Clinical Evaluation of Low Calcium Dialysate AKLK-64－Well contorolled Cross-Over Stndy of AKLK-64 and Kindaly Solution AF-2P－	Yoshihei Hirasawa	Yousuke Ogura	et al.
1992	20	1	131	Clinical Evaluation of Pirmenol in Treatment of Ventricular Premature Contractions －A Multicenter Double-Blind Dose Finding Study－	Hiroshi Kasanuki	Hiroyuki Iinuma	et al.
1992	20	1	161	Phase-Ⅰ Study of Savoxepin, A New Tetracyclic Antipsychotic	Mitsukuni Murasaki	Hirobumi Wakatabe	et al.
1992	20	2	225	Clinical Evaluation of Tandospirone (SM-3997), on Psychosomatic Diseases with Gastrointestinal Complaints－A Comparative Double-Blind Controlled Study with Diazepam and Placebo－	Toshiie Sakata	Tetsuya Nakagawa	et al.
1992	20	2	259	Late Phase Ⅱ Study of a New Anxiolytic, SM-3997 (Tandospirone) on Neurosis	Atsuyoshi Mori	Shunkichi Endo	et al.
1992	20	2	295	Efficacy of a New Anxiolytic, Tandospirone (SM-3997) on Neurosis－A comparative double-blind study with diazepam－	Atsuyoshi Mori	Shunkichi Endo	et al.
1992	20	2	331	Clinical Usefulness of Clentiazem Maleate in Patients with Essential Hypertension－A Multicenter Double-blind Trial Compared with Diltiazem Hydrochloride－	Kaoru Yoshinaga	Tadanao Takeda	Masao Ikeda	et al.
1992	20	2	359	Clinical Utility of TA-3090 in the Treatment of Chronic Stages of Cerebrovascular Disorders－Double-blind study in comparison with Nicardipine－	Kunio Tashiro	Kyuya Kogure	et al.
1992	20	3	447	Clinical Study of Buspirone on Neurosis－A comparative double-blind trial with placebo－	Masahiro Asai	Koichi Ito	et al.
1992	20	3	477	Clinical Evaluation of Angiotensin Converting Enzyme Inhibitor, Trandolapril (RU44570) in Patients with Essential Hypertension－Multi-centerd double-blind comparative study in comparison with enalapril maleate－	Takao Saruta	Osamu Iimura	et al.
1992	20	3	513	Clinical Efficacy of Oral Cibenzoline in Patients with Supraventricular Premature Contraction－A Multi-center Double-blind Comparative Dose-finding Study－	Hiroyuki Iinuma	Saichi Hosoda	et al.
1992	20	3	535	A New PMS System for Collection and Feedback of Information with Computer Network	Yoshihito Ohmori	Ikuo Suzuki	et al.
1993	21	1	21	Clinical Evaluation of NFG Ophthalmic Solution in the Treatment of Viral Conjunctivitis－Multi-center, double-blind study in comparison with placebo－	Shusaku Kitano	Yukio Uchida	et al.
1993	21	1	51	Clinical Evaluation of NFG Ophthalmic Solution in the Treatment of Viral Conjunctivitis (Second Report) －Evaluation of Clnical Sgnificance by Additional Analysis－	Shusaku Kitano	Yukio Uchida
1993	21	1	59	The Clinical Evaluation of B-HT920 (Talipexole Hydrochloride) in Parkinson's Disease－A Multi-Centered Double-Blind Comparateve Study vs. Bromocriptine Mesilate－	Hisayuki Kowa	Yoshikuni Mizuno	Nobuo Yanagisawa
1993	21	1	111	Placebo Controlled Double Blind Study of E0704 (Gangliosides) in Diabetic Peripheral Neuropathy	Takao Nakanishi	Yukio Shigeta	et al.
1993	21	2	161	Therapeutic Effects of Recombinant Human Erythropoietin (SNB-5001) on Anemia Associated with Chronic Renal Failure	Kazuo Ota	Kimihiro Takayama	et al.
1993	21	2	195	Double-blind Trial of Intravenous and Subcutaneous Administrations of Recombinant Human Erythropoietin (SNB-5001) for Anemia in Hemodialysis Patients	Kazuo Ota	Kimihiro Takayama	et al.
1993	21	2	221	Efficacy of a New Antipsychotic, Risperidone, on Schizophrenia－A comparative double-blind study with haloperidol－	Itaru Yamashita	Yukiteru Machiyama	et al.
1993	21	2	261	Double-blind Multicenter Comparative Study with Alfacalcidol of Etidronate Disodium (EHDP) in Involutional Osteoporosis	Hajime Orimo	Kunio Takaoka	et al.
1993	21	3	361	Clinical Utility of E3810 for the Treatment of Duodenal Ulcer－Comparison with Famotidine by Multi-center Double-blind Study－	Jyunji Yoshino	et al.
1993	21	3	383	Clinical Evaluation of Passiflamin (Passiflora Extract) on Neurosis－Multi-center, double-blind study in comparison with Mexazolam－	Kazuo Hasegawa	Yoshio Kudo	et al.
1993	21	3	441	Phase Ⅰ Trial on the Serotonin Reuptake Inhibitor SME3110 (fluvoxamine maleate)	Hirobumi Wakatabe	Eiko Shimada	et al.
1993	21	3	491	Study on Reliability and Validity of the Japanese Version of Yale-Brown Obsessive Compulsive Scale (JY-BOCS)	Michihiko Nakamura	Chiaki Taga	et al.
1994	22	1	61	Clinical Study on Long-term Drug Treatment of Mild Essential Hypertension－Multicenter double-blind trial by group comparison of carteorol and hydrochlorothiazide－
1994	22	1	105	Thrombolytic Therapy of SM-9527 (Duteplase; rt-PA) in Hyperacute Embolic Stroke －The clinical efficacy and safety of thrombolytic agent in a randomaized double-blind study－	Takenori Yamaguchi	Hiroshi Abe	et al.
1994	22	1	141	Phase 1 Study of Remoxipride	Tetsuo Kyohno	Mitsukuni Murasaki	Sadanori Miura
1994	22	2,3	211	Clinical Study of SMC20-051 Nasal Spray in Pain due to Osteoporosis－Phase Ⅱ Dose-finding study－	Takuo Fuita	Seizo Yoshikawa	et al.
1994	22	2,3	233	Clinical Evaluation of SMC20-051 Nasal Spray in the Treatment of Pain due to Osteoporosis－A Multicenter Double-blind Comparative Study with Placebo－	Takuo Fuita	Seizo Yoshikawa	et al.
1995	23	1	13	Clinical Evaluation of KB-2796 (lomerizine hydrochloride) on Migraine－Late Phase Ⅱ Study－	Kunio Tashiro	Naoyuki Kutsuzawa	et al.
1995	23	1	39	Clinical Evaluation of Milnacipran Hudrochloride, a New Antidepressant for Depression snd Depressive State－Phase Ⅲ Clinical Trial with Mianserin Hydrochloride as a Control Drug－	Sadanori Miura	Mitsukuni Murasaki	et al.
1995	23	1	65	Therapeutic Effects of SNB-5001 (Recombinant Human Erythropoietin) on Anemia Associated with Chronic Renal Failure－Double-blind Clinical Study－	Kazuo Ota	Tadao Akizawa	et al.
1995	23	1	87	Long-term Effects of Recombinant Human Erythropoietin (SNB-5001) on Anemia Associated with Chronic Renal Failure	Kazuo Ota	Tadao Akizawa	et al.
1995	23	2	183	Clinical Evaluation of Lomerizine on Migraine－Double-blind Study in Comparison with Dimetotiazine－	Yasuo Fukuuchi	Kunio Tashiro	et al.
1995	23	2	215	Clinical Evaluation of GRS-001(fenofibrate) on Hyperlipidemia －Double-blind Group Comparative Study between Administration in the Morning and Evening－	Yoshiya Hata	Hiroshige Itakura	Yasushi Saito
1995	23	2	247	Study on the Usefulness of GRS-001 in Hyperlipidemia －Double-blind Group Comparison Trial Using Clinofibrate Tablet as the Reference Drug－	Yuichiro Goto	Tsuguhiko Nakai	et al.
1995	23	2	307	Clincal Effects and Pharmacokinetics of GRS-001(Fenofibrate) in Hyperlipidemic Patients with Renal Dysfunction－	Nobuyoshi Hirose	Takao Saruta	Yoshiro Nakamura
1995	23	2	333	Therapeutic Effects of SNB-5001(recombinant human erythropoietin) in Anemia Patients on Continuous Ambulatory Peritoneal Dialysis(CADP) －Double-blind Clinical Study－	Kazuo Ota	Tadao Akizawa	et al.
1995	23	2	357	Reliability of the Japanese Version of Brief Psychiatry Rating Scale(BPRS)	Yasuo Fujii	Ataru Inagaki	et al.
1995	23	3	523	Effect of Fenofibrate(GRS-001) in Hyperlipidemic Patients with Hyperuricemia －A Randomized, Double-Blind, Placebo-Controlled Crossover Study－	Gen Yoshino	Yoshiki Nishizawa	et al.
1995	23	3	553	Effect of Fenofibrate(GRS-001) on Lipoproteins and Lipoprotein Lipase Activity in Patients with Hypertriglyceridemia(Type Ⅱb, Ⅳ and Ⅴ) －Double-Blind, Cross-Over Placebo controlled Study－	Kyosuke Yamamoto	Masato Ageta	et al.
1995	23	3	581	Pharmacokinetics of GRS-001 in the Elderly	Noriaki Nakaya
1995	23	3	595	Efficacy of an Antiplatelet Agent, E5510, for Recurrence of Cerebrovascular Events in Transient Ischemic Patients －A Double-blind Comparison with Ticlopidine Hydrochloride－	Shinichiro Uchiyama	Hideo Tohgi	et al.
1996	24	1	9	Clinical Efficacy of E5510(satigrel), an Antiplatelet Agent, for Preventing Blood Clotting in the Extracorporeal Circuit During Hemodialysis (3) －A Double-blind Comparison with Ticlopidine Hydeochloride－	Satoshi Teraoka	Shozo Koshikawa	et al.
1996	24	1	39	Dose Finding Study of BAY q 7821 (Ipsapirone hydrochloride) on Neurosis －A double-blind, three group comparative study－	Sadanori Miura	Itaru Yamashita	et al.
1996	24	1	71	The Role and Importance of a Third Party on the Management of Postmarketing Drug Surveillance	Shimizu N	Takayama N	Adachi M	Aida T
1997	24	2,3	159	Clinical Evaluation of a New Antipsychotic, Perosirone HCI, on Schizophrenia －A comparative double-blind study with haloperidol－	Koyama T	Miura S	et al.
1997	24	2,3	207	Clinical Evaluation of a Serotonin-2 and Dopamine-2 Receptor Antagonist(SDA), Perospirone HCI on Schizophrenia －A comparative double-blind study with mosapramine HCl－	Nakajima T	Saito M	et al.
1997	24	2,3	249	Analysis of Difference in Judgement between Video Judge Scoring Using VCR Images and Determination of FGIR by the Attending Doctor	Kurihara M
1997	25	1	23	Phase Ⅱ Clinical Study RG83933 Transdermal Estradiol Delivery System －Dose finding study－	Fujimoto S	Sato K	et al.
1997	25	1	43	The Roles of Clinical Trials in Drug Safety Information －Reporting and Analyzing Adverse Events Data in Clinical Trials－
1997	25	1	53	A Comparison of the Frequencies of Adverse Drug Reactions Between Phase Ⅲ Clinical Trials and Postmarketing Follow-up Studies －The Case of Antihypertensive Drugs－	Shimizu N	Ishii M	et al.
1998	26	1	35	Clinical Outcome Prediction of the Drugs for Cerebrovascular Diseases by Tree-based Model	Mogi K	Tsubaki H	Kurihara M
1998	26	1	61	Recruitment of Trial Participants and Protection of Their Human Right and Interest in Clinical Trials for New Drugs	Ishii M
1998	26	2	145	Early Phase Ⅱ Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -8 or 12-weeks, Open Parallel Study, 1mg/day, 2mg/day-	Imai Y	Homma A	Hariguchi S	et al.
1998	26	2	165	Early Phase Ⅱ Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -8～12-weeks Open Study in 3mg/day-	Imai Y	Homma A	Hariguchi S	et al.
1998	26	2	185	Late Phase Ⅱ Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -8-weeks Double-blind Parallel Study in Two Groups, 2mg/day, 0.1mg/day-	Homma A	Imai Y	Hariguchi S	et al.
1998	26	2	209	Late Phase Ⅱ Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -24～48-weeks Double-blind, Placebo-Controlled Study-	Homma A	Imai Y	Hariguchi S	et al.
1998	26	2	233	Late Phase Ⅱ Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -12-weeks dose titration study, 3mg/day, 4mg/day, 5mg/day for every 4 weeks-	Imai Y	Homma A	Hariguchi S	et al.
1998	26	2	251	Late Phase Ⅱ Clinical Study of Acetylcholinesterase Inhibitor E2020 in Patients with Alzheimer-type Dementia -12-weeks Double-blind, Placebo-Controlled Study, 3mg/day, 5mg/day-	Homma A	Imai Y	Hariguchi S	et al.
1999	26	3	419	Clinical Utility of TJ-960 in Patients with Localization Related Epilepsy -Late Phase Ⅱ Study: Multicenter, Double-Blind Study in Comparison with Placebo-	Nakane Y	Yamauchi T	Onuma T	et al.
1999	27	1	83	Roles and Significance of the Subjective Global Judgements by Investigators in Confirmatory Clinical Trials	Tsubaki H	Kurihara M
1999	27	1	101	Phase Ⅰ Study of Quetiapine Fumarate (ICI 204,636,Zeneca) on Healthy Male Volunteer	Murasaki M	Shimada E	Yoshimoto S	et al.
2000	27	3	615	Effect of cilostazol, an antiplatelet agent on transient ischemic attack (TIA)-A double-blind, randomized, controlled trial of cilostazol versus Aspirin-	Gotoh F	Tohgi H	Hirai S	et al.
2000	28	1	97	Long-term safety and efficacy of acetylcholinesterase inhibitor E2020 in patients with Alzheimer-type dementia-52-week open label study-	Tohgi H	Homma A	Imai Y	et al.
2001	28	3	569	Late Phase Ⅱ study of Y-23684 on Neurosis-A placebo-controlled comparative randomized double-blind study-	Miura S	Murasaki M	Kudo Y	et al.
2005	32	1	213	Individual consumption of Mifepristone (RU486) as an oral abortion pill	Matsumoto K	Saotome T
2005	32	1	233	Problems in clinical activities by medical students: Political institutionalization of non-licensed medical practices for education and training purposes	Inoue Y
2005	32	1	259	Survey of the attitude of physicians, patients and clinical research coordinator on clinical trials	Fukunaga T	Ikeda H	Tsukamoto H	et al.
2005	33	1	213	Study on development and evaluation of new over-the-counter drugs by the actual use trial (AUT) using OTC common cold medicine including ibuprofen	Shimizu N	Notani J	Nishikawa T	et al.
2005	33	1	241	Logarithmic equation in Japanese drug pricing rules as a main determinant of the abrupt price rising of growth hormone products	Kamada I	Saio T
2008	35	3	593	Survey results of clinical data management education in medical institutions in Japan	Kanda N	Uno H	Aotani E	Takahashi F
2008	35	3	609	Survey for utilization of Electronic Data Capture in clinical trials conducted by pharmaceutical companies in Japan	Matsuba H	Yamamoto K	Teramukai S	Fukushima M
2008	36	2	393	Questionnaire survey on the institutional review boards in Fukuoka aiming at the construction of the board member education system	Sasaguri T	Shibata T	Ueguchi M	et al.
2008	36	2	421	The activities of IRBs organized in the JACIC member facilities for phase Ⅰ clinical studies	Iijima H	Momma T	Fukazawa I	et al.
2008	36	2	433	Japan Association of Site Management Organizations (JASMO) Institutional Review Board (IRB) survey －Preliminary results and discussion－	Matsushima M	Kobayashi T	Iwakami K	et al.
2009	36	sup26	173	Current status of Japanese universities' management of conflict of interest in clinical research －Survey of conflict of interest policies and rules－	Saotome C	Yoshida K	Teranishi Y
2011	38	4	839	Education and training for ethics board members： Is e-learning the solution?	Tajima M	Nagamura F
2011	39	1	5	Protection of human subjects and compensation for research-related injuries　Proposal of explanation sheet based on survey of the actual status in Japan	Watanabe H	Kageyama S	Kusuoka H	et al.
2011	39	2	395	Current status in the regulation of research that involves human subjects in South Korea and China	Motojima M	Ichikawa I
2011	39	3	601	Present situations and future of the educational environment for the clinical development in Japan： A study based on a questionnaire survey	Somekawa L	Kurokawa T
2012	40	1	179	The central laboratory tests system in clinical trials: From the results of a questionnaire survey of physicians participating in the ASUCA Trial	Todo S	Ueshima K	Kobayashi J	et al.
2012	40	1	187	Background factors of the participating physicians and patients enrollment:From the results of a questionnaire survey for physicians participating in the SAKURA trial	Nakamoto M	Ueshima K	Fukutomi M	et al.
2013	40	2	419	“Cooperative IRB” issues in Japan, United States, Europe, and Asia	Kurihara C	Kageyama S
2013	41	1	209	The application of electromagnetic record to the Clinical Trial-related Documents for the conduct of a clinical trial	Yamaguchi M	Kondo M	Yamamoto M	et al.
2014	41	4	837	The issue of compensation of clinical trial subjects in Japan: The rimonabant lawsuit and the Ihoken Clinical Trial Compensation Guideline 2009	Tsuji J
2014	42	1	107	Clinical development of metreleptin for lipodystrophy	Ito T	Tada H	Tanaka S	et al．
2014	42	1	119	Information disclosure on clinical trials by the national registries and regulatory agencies in Japan, US, and EU	Hoshi J	Fujii H	Takasaki K	et al．
2015	43	1	265 W91	Information usage of patients with muscular dystrophy about clinical trials and its challenge	Noguchi S	Sato H
2016	44	1	151	Preliminary study of neuro-immune cross-talk by gut microbiota for perioperative management in infants with congenital heart disease	Imamura O	Uyeda T	Saito Y	et al．
2016	44	3	405	The key to success in translational research and critical path research 　Part 1: Capability of model animal in translational research 　Part 2: Mechanistic equality in animal disease models and human disease	Fukushima M	Kimura Y
2016	44	3	453	Taught by a dynamism of approval history of U.S. FDA as regards the process of changing labels of new drugs	Morimoto K	Tanimura N	Haraguchi M	Ichimaru K
2017	45	1	9	Ensure reliability of clinical trials: Considering ICH-GCP(R2) and the system of clinical trial in Japan	Kono K
2017	45	1	45	Puzzling out the tragedy of Rennes: The death of a healthy volunteer in the first-in-human trial in France	Kurihara C	Saio T	Nudeshima J
2017	45	2	455	Regulations for clinical trial and human subject protection in the United States	Kurihara C
2017	45	2	481	On the ICMJE clinical trial data sharing statement: Its background and summary of its issue	Kurihara C	Saio T
2017	45	3	609	Threat of terrorism by using chemical and biological warfare agents: Bioluminescence assay as a military biodefense	Imamura O	Mwange VM
2017	45	3	649	International comparative study on clinical trial and human subject protection regulations－International norms, Japan, United States, South Korea, Taiwan, and South Africa－	Kurihara C
2018	45	4	685	Comparison of approval timing and changing process of labels of three new innovative antibody medicines originated in Japan with those of FDA and EMA	Morimoto K	Kobayashi T	Shibata H	Ishii-Watabe A
2018	45	4	701	Application of public healthcare insurance system for the treatment of research-related injury	Nabeoka Y	Kurihara C	Mimura M	Koike R	Watanabe H
2018	46	1	83	Possibility for improvement in Namibian health and drug development: eHealth security for fingerprint authentication	Imamura O	Matsi F	Kaulihowa T	Mgori NK	Kuda Y
2018	46	2	303	Comparing GCP requirements for serious adverse event reporting in the US, EU, and Japan－The impact of GCP renovation on the Japanese Clinical Trials Act 2017－	Ohtsu H	Shinano H	Matsuoka K	Yonemoto N	Sase K
2018	46	2	335	Compensation for clinical trial-related injury in sponsor-initiated or investigator-initiated trials of drugs, medical devices, and regenerative medical products: Commonalities and differences in the applicability of JPILA guidelines	Kurihara C	Koike R	Okada K	et al．
2019	46	3･4	435	Research infrastructure for individual participant data sharing in clinical trials	Kono K
2019	47	1	87	Current FDA or EMA approval status of biopharmaceuticals developed in Japan: focus on hormones, cytokines, and enzymes	Morimoto K	Kobayashi T	Shibata H	Ishii-Watabe A
2019	47	1	99	Availability of the outcomes of clinical studies conducted under the Clinical Trials Act for pharmaceutical application	Araki Y	Sugita H	Sasaki T
2019	47	1	115	Considering the future of clinical research at the turning point of implementation of the new legislation in Japan－Impact of the Clinical Trials Act on Pharmaceutical Industries; Based on the results from the internal survey in JPMA－	Ohshima H	Aoyagi M	Tajima M	et al．
2019	47	1	127	A proposal to improve the implementation of the Clinical Trials Act, based on the comparison of the three research regulations in Japan－Report 1: the quality and safety assurance of investigational medicinal products－	Kurihara C	Suzuki C	Koike R	et al．
2019	47	sup36	135	Roles of an Academic Research Organization (ARO) in the Investigator-Initiated Development of a Medical Device: A representative case of the TITANBRIDGE®	Nishimura T	Sanuki T	Isono T	et al．
2020	47	3	399	Awareness survey on Patient and Public Involvement (PPI) for Japanese drug development professional	Tsuda T	Okura M	Fukuta Y	Imamura K
2020	48	2	355	Utilization of Information and Communication Technology in IRBs as a countermeasure against the COVID-19 outbreak and future challenges	Tsutsumi N	Kurihara C	Matsuyama K	et al．
2020	48	3	535	Considering the future of clinical research at the turning point of implementation of the new legislation in Japan－Consideration of flexible use of clinical evidence and current Japanese regulations; Lessons learned from the COVID-19 pandemic－	Ohshima H	Aoyagi M	Tajima M	et al．
2021	48	sup37	147	Dubious justifiability of involuntary hospitalization: A cross-cultural, system-dynamic analysis	Park H	Saio T	Dhai A	Kurihara C
2021	49	1	7	The effects on sales volume share of value-added generic drugs ～A complex analysis of pharmaceutical companies’ motivation to develop value-added generic drugs～	Hamada C
2021	49	1	29	A study on a strategic model to implement remote auditing	Tsutsumi N	Matsuyama K	Nagashima H	Imamura K
2022	49	3	443	Analysis of epidemiological data including an interaction in symptom occurrence－From the “Nagoya City Cervical Cancer Vaccination Survey”	Shitara S	Morikawa T
2022	50	1	5	The current state of the French Law on Research involving Human Being: As a result of the adjustment of doctrine and practice under the EU regulation	Nudeshima J
2022	50	1	21	Challenges and proposals for improvement of the implementation of the Clinical Trial Act, based on the comparison of the three research regulations in Japan－Report 2: focusing on data-driven research and privacy protection－	Kurihara C	Mimura M	Oi H	et al．
2022	50	2	259	Considering the future of clinical research at the turning point of implementation of the new legislation in Japan －Consideration of regulatory approval system in Japan and ‘Emergency Approval System’ enforced by the amendment of the Pharmaceutical and Medical Device Act in 2022 due to the COVID-19 pandemic－	Ohshima H	Aoyagi M	Tajima M	et al．
2023	50	4	551	Respect for willingness of patients to participate in clinical trials	Otsuka I	Murayama H

up date 2023/2/22